CALCULATION OF
REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
Title of each class of
securities to be registered
|
|
Amount to be
registered
|
|
Maximum offering
price per unit
|
|
Maximum aggregate
offering price
|
|
Amount of
registration fee(1)
|
3.375% Senior Notes due 2020
|
|
$300,000,000
|
|
99.915%
|
|
$299,745,000
|
|
$21,371.82
|
|
|
(1)
|
The registration fee is calculated in accordance with Rule 456(b) and Rule 457(r) under the Securities Act of 1933, as amended.
|
Filed Pursuant
to Rule 424(b)(2)
Registration No. 333-170109
PROSPECTUS SUPPLEMENT
(To prospectus dated October 25, 2010)
$300,000,000
Sigma-Aldrich Corporation
3.375% Senior Notes due 2020
We are offering
$300,000,000 aggregate principal amount of our 3.375% Senior Notes due 2020 (the notes). We will pay interest on these notes semi-annually in arrears on May 1 and November 1 of each year, beginning on May 1, 2011. The notes will mature
on November 1, 2020.
The notes may be redeemed at our option, at any time in whole or from time to time in part, as described
in this prospectus supplement under the caption Description of the NotesOptional Redemption. If we experience a change of control triggering event, we may be required to offer to purchase the notes from holders.
The notes will be our unsecured senior obligations and will rank equally with all of our other unsecured and unsubordinated indebtedness
from time to time outstanding.
We do not intend to apply for listing of the notes on any securities exchange or for inclusion
of the notes in any automated dealer quotation system. Currently, there is no public market for the notes.
Investing in
the notes involves substantial risks. You should carefully consider the risks described under the
Risk Factors
section of this prospectus supplement beginning on page S-6 and similar sections in our filings
with the Securities and Exchange Commission incorporated by reference herein before investing in any of the notes offered hereby.
|
|
|
|
|
|
|
|
|
|
|
Per Note
|
|
|
Total
|
|
Public offering price (1)
|
|
|
99.915
|
%
|
|
$
|
299,745,000
|
|
Underwriting discount
|
|
|
0.650
|
%
|
|
$
|
1,950,000
|
|
Proceeds, before expenses, to us (1)
|
|
|
99.265
|
%
|
|
$
|
297,795,000
|
|
(1)
|
Plus accrued interest, if any, from October 28, 2010, if settlement occurs after such date.
|
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The underwriters expect to deliver the notes only in book-entry form through the facilities of The Depository Trust Company for the accounts of its participants, including Euroclear Bank S.A./N.V., as
operator of the Euroclear System, and Clearstream Banking, société anonyme, on or about October 28, 2010.
Joint
Book-Running Managers
|
|
|
BofA Merrill Lynch
|
|
J.P. Morgan
|
The date of this prospectus supplement is October 25, 2010.
TABLE OF CONTENTS
Prospectus Supplement
We are
responsible for the information contained and incorporated by reference in this prospectus supplement, the accompanying prospectus and in any related free writing prospectus we prepare or authorize. We have not authorized anyone to give you any
other information, and we take no responsibility for any other information that others may give you.
S-i
If you are in a
jurisdiction where offers to sell, or solicitations of offers to purchase, the notes offered by this document are unlawful, or if you are a person to whom it is unlawful to direct these types of activities, then the offer presented in this document
does not extend to you. You should assume that the information contained and incorporated by reference in this prospectus supplement, the accompanying prospectus and any free writing prospectus with respect to this offering filed by us with the
Securities and Exchange Commission (the SEC) is only accurate as of the respective dates of such documents. Our business, financial condition, results of operations and prospects may have changed since those dates.
S-ii
ABOUT THIS PROSPECTUS SUPPLEMENT
This document is in two parts. The first part is this prospectus supplement, which describes the specific terms of this offering of the
notes and also adds to and updates information contained in the accompanying prospectus and the documents incorporated by reference into this prospectus supplement and the accompanying prospectus. The second part, the accompanying prospectus, gives
more general information about us and the debt securities we may offer from time to time under our shelf registration statement, some of which may not apply to this offering of the notes.
If the description of this offering of the notes in the accompanying prospectus is different from the description in this prospectus
supplement, you should rely on the information contained in this prospectus supplement.
You should read this prospectus
supplement, the accompanying prospectus, the documents incorporated by reference into this prospectus supplement and the accompanying prospectus and the additional information described under Where You Can Find More Information and
Information Incorporated by Reference in this prospectus supplement before deciding whether to invest in the notes offered by this prospectus supplement.
Unless we have indicated otherwise, or the context otherwise requires, references in this prospectus supplement and the accompanying prospectus to the Company, we, us
and our refer to Sigma-Aldrich Corporation and its subsidiaries.
You should not consider any information in this
prospectus supplement or the accompanying prospectus to be investment, legal or tax advice. You should consult your own counsel, accountants and other advisers for legal, tax, business, financial and related advice regarding the purchase of any of
the notes offered by this prospectus supplement.
Currency amounts in this prospectus supplement are stated in U.S. dollars.
WHERE YOU CAN FIND MORE INFORMATION
We are subject to the information reporting requirements of the Securities Exchange Act of 1934, as amended (the Exchange
Act), and, in accordance with these requirements, we are required to file periodic reports and other information with the SEC. The reports and other information filed by us with the SEC may be inspected and copied at the public reference
facilities maintained by the SEC as described below.
This prospectus supplement is part of a registration statement that we
filed with the SEC. The registration statement, including the attached exhibits, contains additional relevant information about us. The rules of the SEC allow us to omit from this prospectus supplement and the accompanying prospectus some of the
information included in the registration statement. You may read and copy the registration statement, including the exhibits thereto, and any periodic reports and other information referred to above on file at the SECs Public Reference Room at
100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the operation of the Public Reference Room. The SEC filings are also available to the public from commercial document retrieval services.
These filings are also available at the Internet website maintained by the SEC at
http://www.sec.gov
and may also be inspected and copied at the offices of The NASDAQ Stock Market, 165 Broadway, New York, NY 10006.
S-iii
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
This prospectus supplement and the accompanying prospectus (including the documents incorporated by reference in this prospectus
supplement and the accompanying prospectus) and any free writing prospectus with respect to this offering filed by us with the SEC contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E
of the Exchange Act that involve risk and uncertainty, including financial, business environment and projections, as well as statements that are preceded by, followed by, or that include the words believes, expects,
anticipates, should or similar expressions, and other statements contained herein regarding matters that are not historical facts. Additionally, this prospectus supplement and the accompanying prospectus (including the
documents incorporated by reference in this prospectus supplement and the accompanying prospectus) contain forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs,
including without limitation, statements regarding our expectations, goals, beliefs, intentions and the like regarding future sales, earnings, restructuring charges, cost savings, process improvements, share repurchases, capital expenditures,
acquisitions and other matters. These statements involve assumptions regarding our operations, investments, acquisitions and conditions in the markets we serve.
Although we believe our expectations are based on reasonable assumptions, such statements are subject to risks and uncertainties, including, among others, certain economic, political and technological
factors. Actual results could differ materially from those stated or implied in this document and the documents incorporated in it, due to, but not limited to, such factors as:
|
|
|
global economic conditions;
|
|
|
|
changes in pricing and the competitive environment and the global demand for our products;
|
|
|
|
fluctuations in foreign currency exchange rates;
|
|
|
|
changes in research funding and the success of research and development activities;
|
|
|
|
dependence on uninterrupted manufacturing operations;
|
|
|
|
changes in the regulatory environment in which we operate;
|
|
|
|
changes in worldwide tax rates or tax benefits from domestic and international operations, including the matters described in Note 3 of our Quarterly
Report on Form 10-Q for the quarter ended September 30, 2010 and in Note 10 to the Consolidated Financial Statements in our Form 10-K for the year ended December 31, 2009;
|
|
|
|
exposure to litigation, including product liability claims;
|
|
|
|
the ability to maintain adequate quality standards;
|
|
|
|
reliance on third party package delivery services;
|
|
|
|
failure to achieve planned cost reductions in global supply chain initiatives and restructuring actions;
|
|
|
|
an unanticipated increase in interest rates;
|
|
|
|
failure of planned sales initiatives in our Research and SAFC businesses;
|
|
|
|
other changes in the business environment in which the Company operates;
|
S-iv
|
|
|
the outcome of the outstanding matters described in the Companys Quarterly Report on Form 10-Q for the period ended September 30, 2010 under
Part IItem 2. Managements Discussion and Analysis of Financial Condition and Results of OperationsOther Matters; and
|
|
|
|
the matters referred to under Risk Factors above.
|
These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements included in
this document. These risks and uncertainties, as well as other risks of which we are not aware or which we currently do not believe to be material, may cause our actual future results to be materially different than those expressed in our
forward-looking statements. We do not undertake to update our forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.
S-v
SUMMARY
This summary highlights information from this prospectus supplement and the accompanying prospectus. It is not complete and may not contain all of the information that you should consider before
investing in our notes. We encourage you to read this prospectus supplement, the accompanying prospectus and the documents incorporated by reference in their entirety before making an investment decision, including the information set forth under
the heading Risk Factors.
Sigma-Aldrich Corporation
Sigma-Aldrich Corporation is a leading Life Science and High Technology company. We develop, manufacture, purchase and distribute the
broadest range of high quality chemicals, biochemicals and equipment available throughout the world. These chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical
development and as key components in pharmaceutical, diagnostic and other high technology manufacturing.
We are a Delaware
corporation. Our principal executive offices are located at 3050 Spruce Street, St. Louis, Missouri 63103 and our telephone number is (314) 771-5765. Our website is http://www.sigma-aldrich.com. Information on, or accessible through, this
website is not a part of, and is not incorporated into, this prospectus supplement.
We have a customer-centric organizational
structure featuring our: Research Essentials unit selling biological buffers, cell culture reagents, biochemicals, chemicals, solvents, and other reagents and kits; Research Specialties unit selling organic chemicals, biochemicals, analytical
reagents, chromatography and other laboratory consumables, reference materials and high-purity products; Research Biotech unit supplying immunochemical, molecular biology, cell signaling and neuroscience biochemicals and kits used in biotechnology,
genomic, proteomic and other life science research applications; and our SAFC (Fine Chemicals) unit, which is a top 10 supplier of large-scale organic chemicals and biochemicals used in development and production by pharmaceutical, biotechnology,
industrial, diagnostic and electronics companies.
As of September 30, 2010, we sell over 170,000 different products,
including approximately 40,000 equipment products, to over 92,000 accounts in over 160 countries representing over one million individual customers, including universities, pharmaceutical companies, commercial laboratories, industrial companies,
non-profit organizations, governmental institutions, biotechnology, diagnostic, chemical and electronics companies and hospitals. We also make our chemical products available in larger-scale quantities for manufacturing.
We operate in 40 countries with production facilities in Madison, Milwaukee and Sheboygan, Wisconsin; St. Louis, Missouri; Lenexa,
Kansas; Houston, Texas; Bellefonte and Denver, Pennsylvania; Haverhill and Natick, Massachusetts; Urbana, Illinois; Miamisburg, Ohio; Carlsbad, California; Australia; Canada; France; Germany; India; Ireland; Israel; Japan; Singapore; Switzerland;
Taiwan and the United Kingdom. Biochemicals are primarily produced by extraction and purification from yeast, bacteria and other naturally occurring animal and plant sources. Organic and inorganic chemicals and radiolabeled chemicals are primarily
produced by synthesis. Chromatography media and columns are produced using proprietary chemical synthesis and proprietary preparation processes, similar to the filtration and sample collection processes.
While we manufacture approximately 48,000 of the 130,000 chemical products we offer, we purchase the rest from sources either under
contract or in the open market. However, none of our 10,000 suppliers account for more than 10% of purchases. Regardless of whether a product is produced by us or purchased from suppliers, it is subjected to quality control procedures performed by a
staff of chemists and lab technicians utilizing highly calibrated equipment.
As of September 30, 2010, we hold approximately
580 issued or pending patents, over 620 licenses and approximately 810 registered trademarks and trademark applications worldwide, however other than our brand names, no single patent, license, or trademark is material in relation to our business as
a whole.
S-1
The Offering
The summary below describes the principal terms of the notes. Certain of the terms described below are subject to
important limitations and exceptions. The Description of the Notes section of this prospectus supplement and the Description of Debt Securities section of the accompanying prospectus contain a more detailed description of the
terms of the notes.
Issuer
|
Sigma-Aldrich Corporation.
|
Notes Offered
|
$300,000,000 aggregate principal amount of 3.375% Senior Notes due 2020.
|
Maturity
|
The notes will mature on November 1, 2020.
|
Interest Rate
|
The notes will bear interest at a rate of 3.375% per year.
|
Interest Payment Dates
|
The interest will be payable semi-annually in arrears on May 1 and November 1 of each year, beginning on May 1, 2011. Interest will accrue from October 28, 2010.
|
Optional Redemption
|
We may redeem the notes at our option, at any time in whole or from time to time in part, at a redemption price equal to the greater of:
|
|
|
|
100% of the principal amount of the notes to be redeemed; or
|
|
|
|
the sum of the present values of the remaining scheduled payments of principal and interest on the notes to be redeemed (exclusive of interest accrued
to the date of redemption) from the redemption date through the stated maturity of the notes being redeemed, in each case discounted to the date of redemption on a semi annual basis (assuming a 360 day year consisting of twelve 30 day months) at the
Treasury Rate (as defined in this prospectus supplement) plus 15 basis points.
|
At any time on or after
three months prior to the maturity date, the notes will be redeemable as a whole or in part, at our option, at a redemption price equal to 100% of the principal amount of the notes to be redeemed plus accrued and unpaid interest on the notes to be
redeemed to the date of redemption.
We will also pay the accrued and unpaid interest on the principal amount being redeemed
to the date of redemption.
Offer to Repurchase Upon Change of Control Triggering Event
|
If we experience a Change of Control Triggering Event (as defined in this prospectus supplement) with respect to the notes, unless we have exercised our right to redeem the notes,
each holder of notes will have the right to require us to repurchase all or a portion of such holders notes at a price equal to 101% of the principal amount of the notes repurchased plus accrued and unpaid interest, if any, as described more
fully under Description of the NotesOffer to Repurchase Upon Change of Control Triggering Event.
|
S-2
Ranking
|
The notes will be our senior unsecured indebtedness and will rank equally with all of our other senior unsecured indebtedness from time to time outstanding.
|
Certain Covenants
|
We and our subsidiaries will be limited in our and their ability to do the following:
|
|
|
|
incur secured indebtedness;
|
|
|
|
enter into certain sale and leaseback transactions; and
|
|
|
|
enter into certain mergers, consolidations and sales of substantially all of our assets.
|
The above restrictions are subject to significant exceptions. See Description of Debt SecuritiesConsolidation, Merger,
Conveyance, Sale of Assets and Other Transfers, Description of Debt SecuritiesRestrictions on Liens and Description of Debt SecuritiesRestrictions on Sale and Leaseback Transactions in the accompanying
prospectus.
Use of Proceeds
|
We will use the net proceeds from the sale of the notes, which will be approximately $297 million, after deducting underwriting discounts and our offering expenses, for general corporate
purposes. Such general corporate purposes may include working capital, investments in or extensions of credit to our subsidiaries, capital expenditures, stock repurchases, debt repayment or financing for acquisitions. Pending such use, the proceeds
may be invested temporarily in short-term, interest-bearing, investment-grade securities or similar assets. See Use of Proceeds for more information.
|
Denominations
|
The notes will be issued in minimum denominations of $2,000 and multiples of $1,000 in excess thereof.
|
Form of Notes
|
We will issue the notes in the form of one or more fully registered global notes registered in the name of the nominee of The Depository Trust Company (DTC).
|
Further Issues
|
We may, without the consent of the holders, re-open the notes and, subject to certain tax limitations, issue additional notes on terms identical in all respects to the outstanding
notes offered by this prospectus supplement (except for the date of issuance, the date interest begins to accrue and, in certain circumstances, the first interest payment date), as described under Description of Debt
SecuritiesGeneral. These additional notes, together with the notes offered by this prospectus supplement, shall form a single series with and increase the aggregate principal amount of the series.
|
S-3
Risk Factors
|
You should consider carefully all the information set forth and incorporated by reference in this prospectus supplement and the accompanying prospectus and, in particular, you should evaluate
the specific factors set forth under the heading Risk Factors beginning on page S-6 of this prospectus supplement, as well as the risk factors discussed under the heading Cautionary Statement Concerning Forward-Looking
Statements beginning on page S-iv of this prospectus supplement before deciding whether to invest in the notes.
|
Trustee
|
Deutsche Bank Trust Company Americas.
|
Ratio of
Earnings to Fixed Charges
The following table sets forth the ratio of earnings to fixed charges for the periods
indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended
September 30,
|
|
|
Twelve months ended
December
31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
Ratio of earnings to fixed charges
|
|
|
19.9
|
|
|
|
17.1
|
|
|
|
13.8
|
|
|
|
10.6
|
|
|
|
9.3
|
|
|
|
10.3
|
|
Earnings consist
principally of income from continuing operations before income taxes, plus fixed charges. Fixed charges include interest expense, the portion of rent expense representative of interest and capitalized interest.
S-4
Summary
Consolidated Financial Data
The following table sets forth our summary consolidated financial data and other data for the
periods and at the dates indicated. The summary consolidated financial data as of and for each of the years in the three-year period ended December 31, 2009 have been derived from our audited consolidated financial statements included in our
annual report on Form 10-K for the fiscal year ended December 31, 2009, which is incorporated by reference herein. The historical financial data as of and for each of the nine months ended September 30, 2010 and September 30, 2009
have been derived from our unaudited condensed consolidated financial statements included in our quarterly report on Form 10-Q for the fiscal quarter ended September 30, 2010, which is incorporated by reference herein. The unaudited condensed
consolidated financial statements have been prepared on the same basis as our audited consolidated financial statements and, in the opinion of our management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for
a fair presentation of this data. The results for any interim period are not necessarily indicative of the results that may be expected for a full year.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
September 30,
|
|
|
Fiscal Year Ended
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions, except per share data)
|
|
Statement of Income Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
1,689
|
|
|
$
|
1,575
|
|
|
$
|
2,148
|
|
|
$
|
2,201
|
|
|
$
|
2,039
|
|
Cost of products sold
|
|
|
794
|
|
|
|
772
|
|
|
|
1,058
|
|
|
|
1,071
|
|
|
|
1,003
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
895
|
|
|
|
803
|
|
|
|
1,090
|
|
|
|
1,130
|
|
|
|
1,036
|
|
Selling, general and administrative expenses
|
|
|
405
|
|
|
|
384
|
|
|
|
518
|
|
|
|
561
|
|
|
|
517
|
|
Research and development expenses
|
|
|
49
|
|
|
|
47
|
|
|
|
63
|
|
|
|
65
|
|
|
|
59
|
|
Restructuring costs
|
|
|
13
|
|
|
|
|
|
|
|
9
|
|
|
|
|
|
|
|
|
|
Impairment cost
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
421
|
|
|
|
372
|
|
|
|
500
|
|
|
|
504
|
|
|
|
460
|
|
Interest, net
|
|
|
5
|
|
|
|
8
|
|
|
|
10
|
|
|
|
14
|
|
|
|
22
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
416
|
|
|
|
364
|
|
|
|
490
|
|
|
|
490
|
|
|
|
438
|
|
Provision for income taxes
|
|
|
126
|
|
|
|
110
|
|
|
|
143
|
|
|
|
148
|
|
|
|
127
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
290
|
|
|
$
|
254
|
|
|
$
|
347
|
|
|
$
|
342
|
|
|
$
|
311
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
2.40
|
|
|
$
|
2.08
|
|
|
$
|
2.84
|
|
|
$
|
2.70
|
|
|
$
|
2.38
|
|
Diluted
|
|
$
|
2.36
|
|
|
$
|
2.06
|
|
|
$
|
2.80
|
|
|
$
|
2.65
|
|
|
$
|
2.34
|
|
Weighted average number of shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
121
|
|
|
|
122
|
|
|
|
122
|
|
|
|
126
|
|
|
|
131
|
|
Diluted
|
|
|
123
|
|
|
|
124
|
|
|
|
124
|
|
|
|
129
|
|
|
|
133
|
|
|
|
|
|
|
|
|
|
|
|
|
As of
September
30,
2010
|
|
|
As of
December 31,
2009
|
|
|
|
(unaudited)
|
|
|
|
|
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
500
|
|
|
$
|
373
|
|
Total assets
|
|
|
2,869
|
|
|
|
2,714
|
|
Total debt outstanding
|
|
|
478
|
|
|
|
577
|
|
Total stockholders equity
|
|
|
1,888
|
|
|
|
1,686
|
|
Total liabilities and stockholders equity
|
|
|
2,869
|
|
|
|
2,714
|
|
S-5
RISK FACTORS
An investment in the notes involves certain risks. You should carefully consider the risk factors discussed under the heading Cautionary Statement Concerning Forward-Looking Statements
provided in this prospectus supplement beginning on page S-iv, the risks described under Risk Factors in our most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q, in our Current Report on Form 8-K filed
October 25, 2010, as well as the other information included or incorporated by reference in this prospectus supplement, before making an investment decision. Additional risks and uncertainties not presently known to us or that we currently deem
immaterial may also adversely affect our business or financial performance. Our business, financial condition, or results of operations could be materially adversely affected by any of these risks. The market or trading price of the notes could
decline due to any of these risks or other factors, and you may lose all or part of your investment.
In addition to
the foregoing risks relating to us, the following are additional risks relating to an investment in the notes.
The notes are
effectively subordinated to the existing and future liabilities of our subsidiaries and to our secured debt.
Our
subsidiaries are separate and distinct legal entities from us. The notes are obligations exclusively of Sigma-Aldrich Corporation and are not guaranteed by our subsidiaries, which have no obligation to pay any amounts due on the notes or to provide
us with funds to meet our payment obligations on the notes, whether in the form of dividends, distributions, loans or other payments. Our subsidiaries are not prohibited from incurring additional debt or other liabilities, including senior
indebtedness, or from issuing equity interests that have priority over our interests in the subsidiaries. If our subsidiaries were to incur additional debt or liabilities or to issue equity interests that have priority over our interests in the
subsidiaries, our ability to pay our obligations on the notes could be adversely affected. As of September 30, 2010, our consolidated subsidiaries had no indebtedness outstanding. In addition, any payment of dividends, loans or advances by our
subsidiaries could be subject to statutory or contractual restrictions. Payments to us by our subsidiaries will also be contingent upon the subsidiaries earnings and business considerations. Our right to receive any assets of any of our
subsidiaries upon their bankruptcy, liquidation or reorganization, and therefore the right of the holders of the notes to participate in those assets, will be effectively subordinated to the claims of that subsidiarys creditors, including
trade creditors. In addition, even if we are a creditor of any of our subsidiaries, our rights as a creditor would be subordinate to any security interest in the assets of our subsidiaries and any indebtedness of our subsidiaries senior to that held
by us.
The notes are our senior unsecured obligations and will rank equal in right of payment to our other senior unsecured
debt from time to time outstanding. As of September 30, 2010, we had approximately $
478 million of total indebtedness outstanding on a consolidated basis, all of which would rank equal in right of payment to the notes. The notes are not
secured by any of our assets. Any future claims of secured lenders with respect to assets securing their loans will be prior to any claim of the holders of the notes with respect to those assets. We do not currently have any material secured
obligations.
The terms of the indenture and the notes provide only limited protection against significant corporate events and other
actions we may take that could adversely impact your investment in the notes.
While the indenture and the notes
contain terms intended to provide protection to the holders of the notes upon the occurrence of certain events involving significant corporate transactions, such terms are limited and may not be sufficient to protect your investment in the notes.
The definition of the term Change of Control Triggering Event (as defined in Description of the
NotesOffer to Repurchase upon Change of Control Triggering Event) does not cover a variety of transactions (such as acquisitions by us or recapitalizations) that could negatively affect the value of your notes. If we were to enter into a
significant corporate transaction that would negatively affect the value of the notes but would not constitute a Change of Control Triggering Event, we would not be required to offer to repurchase your notes prior to their maturity.
S-6
Furthermore, the
indenture for the notes does not:
|
|
|
require us to maintain any financial ratios or specific levels of net worth, revenues, income, cash flow or liquidity;
|
|
|
|
limit our ability to incur indebtedness that is equal in right of payment to the notes;
|
|
|
|
restrict our subsidiaries ability to issue securities or otherwise incur indebtedness that would be senior to our equity interests in our
subsidiaries and therefore rank effectively senior to the notes;
|
|
|
|
limit the ability of our subsidiaries to service indebtedness;
|
|
|
|
restrict our ability to repurchase or prepay any other of our securities or other indebtedness; or
|
|
|
|
restrict our ability to make investments or to repurchase or pay dividends or make other payments in respect of our common stock or other securities
ranking junior to the notes.
|
As a result of the foregoing, when evaluating the terms of the notes, you
should be aware that the terms of the indenture and the notes do not restrict our ability to engage in, or to otherwise be a party to, a variety of corporate transactions, circumstances and events that could have an adverse impact on your investment
in the notes.
Our credit ratings may not reflect all risks of your investments in the notes.
Our credit ratings are an assessment by rating agencies of our ability to pay our debts when due. Consequently, real or anticipated
changes in our credit ratings will generally affect the market value of the notes. These credit ratings may not reflect the potential impact of risks relating to the structure or marketing of the notes. Agency ratings are not a recommendation to
buy, sell or hold any security, and may be revised or withdrawn at any time by the issuing organization. Each agencys rating should be evaluated independently of any other agencys rating.
If an active trading market does not develop for the notes, you may be unable to sell your notes or to sell your notes at a price that you deem
sufficient.
The notes are a new issue of securities for which there currently is no established trading market. We do
not intend to apply for listing of the notes on any securities exchange or for quotation of the notes in any automated dealer quotation system. Although certain of the underwriters have informed us that they currently intend to make a market in the
notes after we complete the offering, they have no obligation to do so and may discontinue making a market at any time without notice. No assurance can be given:
|
|
|
that a market for the notes will develop or continue;
|
|
|
|
as to the liquidity of any market that does develop; or
|
|
|
|
as to your ability to sell any notes you may own or the price at which you may be able to sell your notes.
|
We may not be able to repurchase the notes upon a change of control.
Upon the occurrence of specific kinds of change of control events, unless we have exercised our right to redeem the notes, each holder of
notes will have the right to require us to repurchase all or any part of such holders notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the date of purchase. If we experience a Change
of Control Triggering Event (as defined in Description of the NotesOffer to Repurchase upon Change of Control Triggering Event), there can be no assurance that we would have sufficient financial resources available to satisfy
our obligations to repurchase the notes. Our failure to purchase the notes as required under the indenture governing the notes would result in a default under the indenture, which could have material adverse consequences for us and the holders of
the notes. See Description of the NotesOffer to Repurchase Upon Change of Control Triggering Event.
S-7
USE OF PROCEEDS
We will use the net proceeds from the sale of the notes, which will be approximately $297 million, after deducting underwriting discounts and our offering expenses, for general corporate purposes. Such
general corporate purposes may include working capital, investments in or extensions of credit to our subsidiaries, capital expenditures, stock repurchases, debt repayment or financing for acquisitions. As a result, we will retain broad discretion
over the use of the net proceeds of the offering.
Pending such use, the proceeds may be invested temporarily in short-term,
interest-bearing, investment-grade securities or similar assets.
S-8
CAPITALIZATION
The following table sets forth our cash and cash equivalents, total debt and capitalization as of September 30, 2010:
|
|
|
on an actual basis; and
|
|
|
|
on an as adjusted basis to give effect to the receipt and application of the $297 million estimated net proceeds from this offering, after deducting
underwriting discounts and our offering expenses.
|
You should read the data set forth in the table below in
conjunction with our historical consolidated financial statements, including the related notes, which are incorporated by reference herein.
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2010
|
|
|
|
Actual
|
|
|
As Adjusted
|
|
|
|
(in millions)
|
|
Cash and cash equivalents
|
|
$
|
500
|
|
|
$
|
797
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes payable and current maturities of long-term debt
|
|
|
378
|
|
|
|
378
|
|
Long-term debt
|
|
|
|
|
|
|
|
|
3.375% Senior Notes offered hereby
|
|
|
|
|
|
|
300
|
|
Senior Notes, due December 5, 2011
|
|
|
100
|
|
|
|
100
|
|
|
|
|
|
|
|
|
|
|
Total debt
|
|
|
478
|
|
|
|
778
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
Common stock, $1.00 par value; 300 shares authorized; 202 shares issued; 121 shares outstanding
|
|
|
202
|
|
|
|
202
|
|
Capital in excess of par value
|
|
|
175
|
|
|
|
175
|
|
Common stock in treasury, at cost, 81 shares
|
|
|
(2,042
|
)
|
|
|
(2,042
|
)
|
Retained earnings
|
|
|
3,462
|
|
|
|
3,462
|
|
Accumulated other comprehensive income
|
|
|
91
|
|
|
|
91
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
1,888
|
|
|
|
1,888
|
|
|
|
|
|
|
|
|
|
|
Total capitalization
|
|
$
|
2,366
|
|
|
$
|
2,666
|
|
|
|
|
|
|
|
|
|
|
S-9
DESCRIPTION OF THE NOTES
The following description is a summary of the terms of the notes being offered. The descriptions in this prospectus supplement and the accompanying prospectus contain descriptions of certain terms of
the notes and the indenture but do not purport to be complete and are subject to, and are qualified in their entirety by reference to, all of the provisions of the indenture which has been filed as an exhibit to the registration statement of which
this prospectus supplement and the accompanying prospectus are a part, including the definitions of specified terms used in the indenture, and to the Trust Indenture Act of 1939, as amended. Wherever particular articles, sections or defined terms of
the indenture are referred to, it is intended that those articles, sections or defined terms will be incorporated herein by reference, and the statement in connection with which reference is made is qualified in its entirety by the article, section
or defined term in the indenture. This summary supplements the description of the debt securities in the accompanying prospectus and, to the extent it is inconsistent, replaces the description in the accompanying prospectus.
General
The notes will
constitute a series of securities under the indenture referred to below and will be issued only in fully registered form in minimum denominations of $2,000 and multiples of $1,000 in excess thereof. The notes will mature on the date set forth below.
The notes will be issued under an indenture to be entered into between us and Deutsche Bank Trust Company Americas, as
trustee. The indenture contains the full legal text of the matters described in this section. This section and the accompanying prospectus summarize material terms of the indenture and the senior notes.
There is no limit on the aggregate principal amount of notes that we may issue under the indenture. Subject to certain tax limitations,
we reserve the right, from time to time and without the consent of any holders of the notes, to re-open such series of notes on terms identical in all respects to the outstanding notes of such series (except the date of issuance, the date interest
begins to accrue and, in certain circumstances, the first interest payment date), so that such additional notes shall be consolidated with, form a single series with and increase the aggregate principal amount of the notes of such series.
The notes will mature on November 1, 2020. The notes will bear interest at 3.375%. We will pay
interest on the notes semi-annually in arrears on May 1 and November 1 of each year, beginning May 1, 2011, to the record holders at the close of business on the preceding
April 15 or October 15 (whether or not a business day). Interest will be computed on the basis of a 360-day year consisting of twelve 30-day months.
Ranking
The notes will be our senior unsecured indebtedness and will rank
equally with all of our other senior unsecured indebtedness from time to time outstanding.
Optional Redemption
We may redeem the notes at our option, at any time in whole or from time to time in part, at a redemption price equal to the greater of:
|
|
|
100% of the principal amount of the notes to be redeemed; or
|
|
|
|
the sum of the present values of the remaining scheduled payments of principal and interest on the notes to be redeemed (exclusive of interest accrued
to the date of redemption) from the redemption date through the stated maturity of the notes being redeemed, in each case discounted to the date of redemption on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the
Treasury Rate (as defined below) plus 15 basis points.
|
S-10
At any time on or
after three months prior to the maturity date, the notes will be redeemable as a whole or in part, at our option, at a redemption price equal to 100% of the principal amount of the notes to be redeemed plus accrued and unpaid interest on the notes
to be redeemed to the date of redemption.
In each case, we will pay accrued and unpaid interest on the principal amount being
redeemed to the date of redemption.
Treasury Rate means, with respect to any date of redemption, the rate per
year equal to: (1) the yield, under the heading which represents the average for the immediately preceding week, appearing in the most recently published statistical release designated H.15(519) or any successor publication which is
published weekly by the Board of Governors of the Federal Reserve System and which establishes yields on actively traded United States Treasury securities adjusted to constant maturity under the caption Treasury Constant Maturities, for
the maturity corresponding to the applicable Comparable Treasury Issue; provided that, if no maturity is within three months before or after the remaining term of the notes to be redeemed, yields for the two published maturities most closely
corresponding to the applicable Comparable Treasury Issue shall be determined and the Treasury Rate shall be interpolated or extrapolated from those yields on a straight line basis, rounding to the nearest month; or (2) if such release (or any
successor release) is not published during the week preceding the calculation date or does not contain such yields, the rate per year equal to the semi-annual equivalent yield to maturity of the applicable Comparable Treasury Issue, calculated using
a price for the applicable Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for that date of redemption.
Comparable Treasury Issue means the United States Treasury security selected by the Quotation Agent that would be utilized, at the time of selection and in accordance with customary financial
practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of the debt securities.
Comparable Treasury Price means, with respect to any date of redemption, (1) the average of three Reference Treasury Dealer Quotations for the date of redemption, after excluding the
highest and lowest Reference Treasury Dealer Quotations or (2) if the Quotation Agent obtains fewer than four Reference Treasury Dealer Quotations, the average of all such Reference Treasury Dealer Quotations.
Quotation Agent means one of the Reference Treasury Dealers appointed by us as Quotation Agent.
Reference Treasury Dealer means (1) each of Banc of America Securities LLC and J.P. Morgan Securities LLC and their
respective successors, unless any of them ceases to be a primary U.S. Government securities dealer in New York City (a Primary Treasury Dealer), in which case we shall substitute another Primary Treasury Dealer and (2) any other
Primary Treasury Dealer we select.
Reference Treasury Dealer Quotations means, with respect to each Reference
Treasury Dealer and any date of redemption, the average, as determined by the Quotation Agent of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the
Quotation Agent by that Reference Treasury Dealer at 5:00 P.M., New York City time, on the third business day preceding that date of redemption.
Notice of redemption will be mailed at least 30 but not more than 60 days before the redemption date to each holder of record of the notes to be redeemed at its registered address. If less than all of the
notes are to be redeemed at any time, the trustee will select notes to be redeemed on a pro rata basis, by lot, or by any other method the trustee deems fair and appropriate. The notice of redemption for the notes will state, among other things, the
amount of notes to be redeemed, the redemption date, the manner in which the redemption price will be calculated and the place or places that payment will be made upon presentation and surrender of notes to be redeemed. Unless we default in the
payment of the redemption price, interest will cease to accrue on any notes that have been called for redemption at the redemption date.
S-11
Offer to Repurchase Upon Change of
Control Triggering Event
Upon the occurrence of a Change of Control Triggering Event with respect to the notes, unless we
have exercised our right to redeem the notes as described under Optional Redemption by giving irrevocable notice to the trustee in accordance with the indenture, each holder of notes will have the right to require us to purchase
all or a portion of such holders notes pursuant to the offer described below (the Change of Control Offer), at a purchase price equal to 101% of the principal amount thereof plus accrued and unpaid interest, if any, up to but not
including the date of purchase (the Change of Control Payment), subject to the rights of holders of notes on the relevant record date to receive interest due and owing on the relevant interest payment date.
Unless we have exercised our right to redeem the notes, within 30 days following the date upon which the Change of Control Triggering
Event occurs or, at our option, prior to any Change of Control but after the public announcement of the pending Change of Control, we will be required to send, by first class mail, a notice to each holder of notes to their addresses as set forth in
the register, with a copy to the trustee, which notice will govern the terms of the Change of Control Offer. Such notice will state, among other things, the purchase date, which must be no earlier than 30 days nor later than 60 days from the date
such notice is mailed, other than as may be required by law (the Change of Control Payment Date). The notice, if mailed prior to the date of consummation of the Change of Control, will state that the Change of Control Offer is
conditioned on the Change of Control being consummated on or prior to the Change of Control Payment Date.
On the Change of
Control Payment Date, we will, to the extent lawful:
|
|
|
accept or cause a third party to accept for payment all notes or portions of notes properly tendered pursuant to the Change of Control Offer;
|
|
|
|
deposit or cause a third party to deposit with the paying agent an amount equal to the Change of Control Payment in respect of all notes or portions of
notes properly tendered; and
|
|
|
|
deliver or cause to be delivered to the trustee the notes properly accepted together with an officers certificate stating the aggregate principal
amount of notes or portions of notes being repurchased.
|
We will not be required to make a Change of Control
Offer with respect to the notes if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for such an offer made by us and such third party purchases all the notes properly tendered and not
withdrawn under its offer. In addition, we will not repurchase any notes if there has occurred and is continuing on the Change of Control Payment Date an event of default under the indenture, other than a default in the payment of the Change of
Control Payment on the Change of Control Payment Date.
We must comply in all material respects with the requirements of Rule
14e-1 under the Exchange Act, and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the notes as a result of a Change of Control Triggering Event. To the
extent that the provisions of any such securities laws or regulations conflict with the Change of Control Offer provisions of the notes, we will be required to comply with those securities laws and regulations and will not be deemed to have breached
our obligations under the Change of Control Offer provisions of the notes by virtue of any such conflict.
For purposes of the
foregoing discussion of a Change of Control Offer, the following definitions are applicable:
Change of Control
means the occurrence of any of the following after the date of issuance of the notes:
(1) the direct or
indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of our assets and the assets of our subsidiaries taken as a whole
to any person or group (as those terms are used in Section 13(d)(3) of the Exchange Act) other than to us or one of our subsidiaries;
S-12
(2)
the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any person or group (as those terms are used in Section 13(d)(3) of the Exchange Act) (other
than us or one of our subsidiaries) becomes the beneficial owner (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of our Voting Stock representing a majority of the voting power of our outstanding
Voting Stock;
(3) we consolidate with, or merge with or into, any Person, or any Person consolidates with, or
merges with or into, us, in any such event pursuant to a transaction in which any of our outstanding Voting Stock or Voting Stock of such other Person is converted into or exchanged for cash, securities or other property, other than any such
transaction where our Voting Stock outstanding immediately prior to such transaction constitutes, or is converted into or exchanged for, Voting Stock representing a majority of the voting power of the Voting Stock of the surviving Person immediately
after giving effect to such transaction;
(4) the first day on which the majority of the members of our board
of directors cease to be Continuing Directors; or
(5) the adoption by our stockholders of a plan relating to
our liquidation or dissolution.
Notwithstanding the foregoing, a transaction (or series of related transactions) will not be
deemed to involve a change of control under clause (2) above if (i) we become a direct or indirect wholly-owned subsidiary of a holding company and (ii)(A) the direct or indirect holders of the Voting Stock of such holding company
immediately following that transaction are substantially the same as the holders of our Voting Stock immediately prior to that transaction or (B) immediately following that transaction no person (as that term is used in Section 13(d)(3) of
the Exchange Act) (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of such holding company.
Change of Control Triggering Event means, with respect to the notes, (i) the rating of such notes is lowered by each of
the Rating Agencies on any date during the period (the Trigger Period) commencing on the earlier of (a) the occurrence of a Change of Control and (b) the first public announcement by us of any Change of Control (or pending
Change of Control), and ending 60 days following consummation of such Change of Control (which Trigger Period will be extended following consummation of a Change of Control for so long as any of the Rating Agencies has publicly announced that it is
considering a possible ratings change), and (ii) such notes are rated below Investment Grade by each of the Rating Agencies on any day during the Trigger Period; provided that a Change of Control Trigger Event will not be deemed to have
occurred in respect of a particular Change of Control if each Rating Agency making the reduction in rating does not publicly announce or confirm or inform the trustee at our or its request that the reduction was the result, in whole or in part, of
any event or circumstance comprised of or arising as a result of, or in respect of, the Change of Control.
Notwithstanding
the foregoing, no Change of Control Triggering Event will be deemed to have occurred in connection with any particular Change of Control unless and until such Change of Control has actually been consummated.
Continuing Director means, as of any date of determination, any member of our board of directors who:
(1) was a member of our board of directors on the date of the issuance of the notes; or
(2) was nominated for election or elected or appointed to our board of directors with the approval of a majority of the
Continuing Directors who were members of our board of directors at the time of such nomination, election or appointment (or such lesser number comprising a majority of a nominating committee if authority for such nomination, election or appointment
has been delegated to a nominating committee whose authority and composition have been approved by at least a majority of the directors who
S-13
were Continuing Directors at the time such committee was formed) either by a specific vote or by approval of our proxy statement in which such member was named as a nominee for election as a
director, without objection to such nomination or otherwise.
Holders would not be entitled to require us to purchase the
notes in certain circumstances involving a significant change in the composition of our board of directors, including in connection with a proxy contest where our board of directors does not approve a dissident slate of directors but approves them
as Continuing Directors, even if our board of directors initially opposed the directors.
Investment Grade means a
rating of Baa3 or better by Moodys (or its equivalent under any successor rating category of Moodys) and a rating of BBB- or better by S&P (or its equivalent under any successor rating category of S&P), and the equivalent
investment grade credit rating from any replacement rating agency or rating agencies selected by us under the circumstances permitting us to select a replacement rating agency and in the manner for selecting a replacement rating agency, in each case
as set forth in the definition of Rating Agency.
Moodys means Moodys Investors Service,
Inc., a subsidiary of Moodys Corporation, and its successors.
Person means any individual, corporation,
partnership, limited liability company, business trust, association, joint-stock company, joint venture, trust, incorporated or unincorporated organization or government or any agency or political subdivision thereof.
Rating Agency means each of Moodys and S&P; provided, that if any of Moodys or S&P ceases to provide
rating services to issuers or investors, we may appoint another nationally recognized statistical rating organization within the meaning of Rule 15c3-1(c)(2)(vi)(F) under the Exchange Act as a replacement for such Rating Agency; provided
that we shall give notice of such appointment to the trustee.
S&P means Standard & Poors
Ratings Services, a division of The McGraw-Hill Companies, Inc., and its successors.
Voting Stock of any
specified Person as of any date means the capital stock of such Person that is at the time entitled to vote generally in the election of the board of directors of such Person.
The definition of Change of Control includes a phrase relating to the direct or indirect sale, lease, transfer, conveyance or other disposition of all or substantially all of our assets and
the assets of our subsidiaries taken as a whole. Although there is a limited body of case law interpreting the phrase substantially all, there is no precise, established definition of the phrase under applicable law. Accordingly, the
applicability of the requirement that we offer to repurchase the notes as a result of a sale, lease, transfer, conveyance or other disposition of less than all of our assets and the assets of our subsidiaries taken as a whole to another
person or group (as those terms are used in Section 13(d)(3) of the Exchange Act) may be uncertain.
S-14
CERTAIN UNITED STATES FEDERAL INCOME AND ESTATE TAX CONSIDERATIONS
The following is a summary of the material U.S. federal income and, in the case of non-U.S. holders (as defined below), certain estate
tax consequences of the acquisition, ownership, and disposition of the notes. This summary is generally limited to holders that acquire the notes pursuant to this offering (at the price indicated on the cover of this prospectus supplement) and hold
the notes as capital assets (generally, property held for investment) for U.S. federal income tax purposes. This discussion does not describe all of the U.S. federal income tax consequences that may be relevant to a holder in light of
its particular circumstances or to holders subject to special rules, including, without limitation, tax-exempt organizations, holders subject to the U.S. federal alternative minimum tax, dealers in securities or currencies, financial institutions,
insurance companies, regulated investment companies, real estate investment trusts, certain former citizens or residents of the United States, controlled foreign corporations, passive foreign investment companies, partnerships, S corporations or
other pass-through entities, U.S. holders (as defined below) whose functional currency is not the U.S. dollar, and persons that hold the notes in connection with a straddle, hedging, conversion or other risk-reduction transaction.
The U.S. federal income tax consequences set forth below are based upon the Internal Revenue Code of 1986, as amended (the
Code) and applicable Treasury regulations, court decisions, and rulings and pronouncements of the Internal Revenue Service (IRS), all as in effect on the date hereof, and all of which are subject to change, or differing
interpretations at any time with possible retroactive effect. There can be no assurance that the IRS will not challenge one or more of the tax consequences described herein, and the Company has not sought any ruling from the IRS with respect to
statements made and conclusions reached in this discussion, and there can be no assurance that the IRS will agree with such statements and conclusions.
As used herein, the term U.S. holder means a beneficial owner of a note that is for U.S. federal income tax purposes:
|
|
|
an individual who is a citizen or resident of the United States;
|
|
|
|
a corporation, or other entity taxable as a corporation for U.S. federal income tax purposes, that is created or organized in or under the laws of the
United States, any state thereof or the District of Columbia;
|
|
|
|
an estate the income of which is subject to U.S. federal income taxation regardless of its source; or
|
|
|
|
a trust, if a court within the United States is able to exercise primary jurisdiction over its administration and one or more U.S. persons have
authority to control all of its substantial decisions, or if the trust has a valid election in effect under applicable Treasury regulations to be treated as a U.S. person.
|
As used herein, the term non-U.S. holder means a beneficial owner of a note that is neither a U.S. holder nor a partnership
or an entity treated as a partnership for U.S. federal income tax purposes.
If a partnership (including any entity treated as
a partnership for U.S. federal income tax purposes) is a beneficial owner of a note, the tax treatment of a partner in the partnership will generally depend upon the status of the partner and the activities of the partnership. A beneficial owner
that is a partnership and partners in such a partnership should consult their tax advisors about the U.S. federal income tax consequences of the acquisition, ownership and disposition of the notes.
This summary does not address the tax consequences arising under any state, local, or foreign law. Furthermore, this summary does not
consider the effect of the U.S. federal estate or gift tax laws (except as set forth below with respect to certain U.S. federal estate tax consequences to non-U.S. holders).
S-15
Investors
considering the acquisition of the notes should consult their own tax advisors with respect to the application of the U.S. federal income tax laws to their particular situation, as well as any tax consequences arising under the U.S. federal estate
or gift tax rules or under the laws of any state, local, or foreign taxing jurisdiction or under any applicable tax treaty.
Possible
Treatment as Contingent Payment Debt Instruments
We may be obligated to pay amounts in excess of the stated interest or
principal on the notes, including as described under Description of the NotesOptional Redemption, and Description of the NotesOffer to Repurchase Upon Change of Control Triggering Event. These potential payments
may implicate the provisions of Treasury regulations relating to contingent payment debt instruments. According to the applicable Treasury regulations, certain contingencies will not cause a debt instrument to be treated as a contingent
payment debt instrument if such contingencies, as of the date of issuance, are remote or incidental. We intend to take the position that the foregoing contingencies are remote or incidental, and we do not intend to treat the notes as contingent
payment debt instruments. Our determination regarding the remoteness of such contingency is binding on each U.S. holder unless a U.S. holder explicitly discloses to the IRS, in the proper manner, that its determination is different than ours.
Our determination is not binding on the IRS and it is possible that the IRS may take a different position regarding the
likelihood of such additional payments, in which case, if that position were sustained, the timing, amount and character of income recognized with respect to a note may be substantially different than described herein and a holder may be required to
recognize income significantly in excess of payments received and may be required to treat as interest income all or a portion of any gain recognized on the disposition of a note. This summary assumes that the IRS will not take a different position,
or, if it takes a different position, that such position will not be sustained. Prospective purchasers should consult their own tax advisors as to the tax considerations that relate to the possibility of additional payments.
U.S. Holders
Payments of
Interest
A U.S. holder will be required to recognize as ordinary income any interest received or accrued on the notes
in accordance with the U.S. holders regular method of accounting.
Original Issue Discount
It is expected that the notes will not be issued with an issue price that is less than their stated redemption price at maturity by more
than the statutory
de minimis
amount. As a result, the notes will not be subject to the original issue discount (OID) rules. If, however, the stated redemption price at maturity (generally equal to the sum of all
payments required under the notes other than payments of qualified stated interest) of the notes exceeds the issue price by more than a
de minimis
amount, U.S. holders will be required to include OID in income for U.S. federal income tax
purposes as it accrues under a constant yield method, regardless of such U.S. holders method of accounting. As a result, U.S. holders may be required to include OID in taxable income prior to the receipt of cash by such U.S. holders.
Sale, Redemption, Exchange or Other Taxable Disposition of Notes
A U.S. holder will generally recognize gain or loss on the sale, redemption, exchange, or other taxable disposition of a note. A U.S.
holder will generally recognize gain or loss in an amount equal to the difference between (i) the proceeds received by the holder in exchange for such note (less an amount attributable to any accrued but unpaid interest not previously included
in income, which will be treated as a payment of interest for U.S. federal income tax purposes) and (ii) the U.S. Holders adjusted tax basis in the note. The proceeds received by a U.S. holder will include the amount of any cash and the
fair-market value of any other property received for
S-16
the note. In general, a U.S. holders adjusted tax basis in a note will equal the amount paid for the note. Such gain or loss recognized by a U.S. holder on a disposition of a note will be
capital gain or loss and will be long-term capital gain or loss if the holder held the note for more than one year. Net long-term capital gains of non-corporate U.S. holders (including individuals) are generally eligible for taxation at preferential
rates. The deductibility of capital losses is subject to certain limitations.
Information Reporting and Backup Withholding
Generally, U.S. holders will be subject to information reporting on payments of interest on the notes and the
proceeds from a sale or other disposition of the notes. Unless a U.S. holder is an exempt recipient such as a corporation, a backup withholding tax (currently at a rate of 28% but scheduled to increase to 31% for taxable years beginning on or after
January 1, 2011) may apply to such payments if the U.S. holder (i) fails to furnish a taxpayer identification number (TIN) within a reasonable time after a request therefor; (ii) furnishes an incorrect TIN; (iii) is
notified by the IRS that it failed to report interest or dividends properly; or (iv) failed, under certain circumstances, to provide a certified statement, signed under penalty of perjury that the TIN provided is correct and that such U.S.
holder is not subject to backup withholding. Backup withholding is not an additional tax. Any amount withheld from a payment to a U.S. holder under these rules will be allowed as a credit against such holders U.S. federal income tax liability
and may entitle such holder to a refund, provided that the required information is furnished timely to the IRS.
Non-U.S. Holders
Payments of Interest
Interest paid on a note by us or our agent to a non-U.S. holder will qualify for the portfolio interest exemption and will not be subject to U.S. federal income tax or withholding tax,
provided that such interest income is not effectively connected with a U.S. trade or business of the non-U.S. holder (or, if a tax treaty applies, is not attributable to a U.S. permanent establishment or fixed base maintained by the non-U.S. holder
within the United States); and provided that the non-U.S. holder:
|
|
|
does not actually or by attribution own 10% or more of the combined voting power of all classes of our stock entitled to vote;
|
|
|
|
is not a controlled foreign corporation for U.S. federal income tax purposes that is related to us actually or by attribution through stock ownership;
|
|
|
|
is not a bank that acquired the note in consideration for an extension of credit made pursuant to a loan agreement entered into in the ordinary course
of business; and
|
|
|
|
either (a) provides IRS Form W-8BEN (or other applicable IRS Form W-8) signed under penalties of perjury that includes the non-U.S. holders
name and address, and certifies as to non-United States status in compliance with applicable law and regulations; or (b) is a securities clearing organization, bank or other financial institution that holds customers securities in the
ordinary course of its trade or business and provides a statement to us or our agent under penalties of perjury in which it certifies that such an IRS Form W-8BEN (or other applicable IRS Form W-8) has been received by it from the non-U.S. holder or
qualifying intermediary and furnishes us or our agent with a copy. The Treasury regulations provide special certification rules for notes held by a foreign partnership and other intermediaries.
|
If such non-U.S. holder cannot satisfy the requirements described above, payments of interest made to the non-U.S. holder will be subject
to the 30% U.S. federal withholding tax unless such holder provides us with a properly executed IRS Form W-8BEN claiming an exemption from (or reduction of) withholding under the benefit of a treaty.
S-17
If interest on a note
is effectively connected with a U.S. trade or business by a non-U.S. holder and, if a tax treaty applies, is attributable to a U.S. permanent establishment or fixed base maintained by the non-U.S. holder within the United States, the non-U.S. holder
generally will not be subject to withholding if the non-U.S. holder complies with applicable IRS certification requirements (i.e., by delivering a properly executed IRS Form W-8ECI) and generally will be subject to U.S. federal income tax on a
net-income basis at regular graduated rates in the same manner as if the holder were a U.S. holder. In the case of a non-U.S. holder that is a corporation, such effectively connected income also may be subject to the additional branch profits tax,
which generally is imposed on a foreign corporation on the deemed repatriation from the United States of effectively connected earnings and profits at a 30% rate (or such lower rate as may be prescribed by an applicable tax treaty).
Sale, Redemption, Exchange or Other Taxable Disposition of Notes
The 30% U.S. federal withholding tax generally will not apply to any gain that a non-U.S. holder realizes on the sale, redemption, exchange or other disposition of a note.
Any gain realized by a non-U.S. holder on the disposition of a note generally will not be subject to U.S. federal income tax, unless:
|
|
|
the gain is effectively connected with the conduct of a U.S. trade or business by the non-U.S. holder and, if required by an applicable tax treaty, the
gain is attributable to a permanent establishment maintained in the United States by the non-U.S. holder; or
|
|
|
|
the non-U.S. holder is an individual who is present in the United States for 183 days or more in the taxable year of that disposition, and certain
other conditions are met or the non-U.S. holder is subject to Code provisions applicable to certain U.S. expatriates.
|
A non-U.S. holder should consult his or her tax advisor regarding the tax consequences of the acquisition, ownership and disposition of the notes.
Information Reporting and Backup Withholding
Information
Reporting.
The payment of interest to a non-U.S. holder is generally not subject to information reporting on IRS Form 1099 if applicable certification requirements (for example, by delivering a properly executed IRS Form W-8BEN) are satisfied.
The payment of proceeds from the sale or other disposition of a note by a broker to a non-U.S. holder is generally not subject to information reporting if:
|
|
|
the beneficial owner of the note certifies the owners non-U.S. status under penalties of perjury (i.e., by providing a properly executed IRS Form
W-8BEN), or otherwise establishes an exemption; or
|
|
|
|
the sale or other disposition of the note is effected outside of the United States by a foreign office, unless the broker is:
|
|
|
|
a foreign person that derives 50% or more of its gross income for certain periods from activities that are effectively connected with the conduct of a
trade or business in the United States;
|
|
|
|
a controlled foreign corporation for U.S. federal income tax purposes; or
|
|
|
|
a foreign partnership more than 50% of the capital or profits of which is owned by one or more U.S. persons or which engages in a U.S. trade or
business.
|
S-18
In addition to the
foregoing, we must report annually to the IRS and to each non-U.S. holder on IRS Form 1042-S the entire amount of interest payment on the notes. This information may also be made available to the tax authorities in the country in which the non-U.S.
holder resides under the provisions of an applicable income tax treaty or other agreement.
Backup Withholding.
Backup
withholding (currently at a rate of 28% but scheduled to increase to 31% for taxable years beginning on or after January 1, 2011) is required only on payments that are subject to the information reporting requirements, discussed above, and only
if other requirements are satisfied. Even if the payment of proceeds from the sale or other disposition of a note were subject to the information reporting requirements, the payment of proceeds from a sale or other disposition outside the United
States would not be subject to backup withholding unless the payor has actual knowledge that the payee is a U.S. person. Backup withholding does not apply when any other provision of the Code requires withholding. For example, if interest is subject
to the withholding tax described above under Payments of Interest, backup withholding will not also be imposed. Thus, backup withholding may be required on payments subject to information reporting, but not otherwise subject to
withholding.
Backup withholding is not an additional tax. Any amount withheld from a payment to a non-U.S. holder under these
rules will be allowed as a credit against such holders U.S. federal income tax liability and may entitle such holder to a refund provided that the required information is furnished timely to the IRS.
U.S. Estate Tax
A note
held, or treated as held, by an individual who is not a citizen or resident of the United States, as specifically defined for U.S. federal estate tax purposes, at the time of death will not be included in the decedents gross estate for U.S.
federal estate tax purposes, provided that at the time of death the non-U.S. holder does not own, actually or by attribution, 10% or more of the total combined voting power of all classes of our stock entitled to vote, and provided that at the time
of death payments with respect to such note would not have been effectively connected with the conduct of a trade or business within the United States by such non-U.S. holder.
The U.S. federal income and estate tax summary set forth above is included for general information only and may not be applicable depending upon your particular situation. You should consult your own
tax advisors with respect to the tax consequences to you of the acquisition, ownership and disposition of the notes, including the tax consequences under state, local, foreign and other tax laws and the possible effects of changes in federal or
other tax laws.
S-19
UNDERWRITING
Subject to the terms and conditions contained in an underwriting agreement, dated as of the date of this prospectus supplement between us and the underwriters named below, for whom Banc of America
Securities LLC is acting as representatives we have agreed to sell to each underwriter, and each underwriter has severally agreed to purchase from us, the principal amount of notes that appears opposite its name in the table below:
|
|
|
|
|
Underwriter
|
|
Principal amount of notes
|
|
Banc of America Securities LLC
|
|
$
|
138,000,000
|
|
J.P. Morgan Securities LLC
|
|
|
108,000,000
|
|
Mitsubishi UFJ Securities (USA), Inc.
|
|
|
18,000,000
|
|
Wells Fargo Securities, LLC
|
|
|
18,000,000
|
|
U.S. Bancorp Investments, Inc.
|
|
|
6,000,000
|
|
Comerica Securities, Inc.
|
|
|
3,000,000
|
|
Deutsche Bank Securities Inc.
|
|
|
3,000,000
|
|
The Williams Capital Group, L.P.
|
|
|
3,000,000
|
|
UBS Securities LLC
|
|
|
3,000,000
|
|
|
|
|
|
|
Total
|
|
$
|
300,000,000
|
|
|
|
|
|
|
The underwriters are offering the notes subject to their acceptance of the notes from us and subject to
prior sale. The underwriting agreement provides that the obligations of the several underwriters to pay for and accept delivery of the notes offered by this prospectus supplement are subject to certain conditions. The underwriters are obligated to
take and pay for all of the notes offered by this prospectus supplement if any such notes are taken.
The underwriters
initially propose to offer the notes to the public at the public offering price that appears on the cover page of this prospectus supplement. In addition, the underwriters initially propose to offer the notes to certain dealers at prices that
represent a concession not in excess of 0.400% of the principal amount of the notes. Any underwriter may allow, and any such dealer may reallow, a concession not in excess of 0.250% of the principal amount of the notes to certain other dealers.
After the initial offering of the notes, the underwriters may from time to time vary the offering price and other selling terms. The underwriters may offer and sell notes through certain of their affiliates.
The following table shows the underwriting discount that we will pay to the underwriters in connection with the offering of the notes:
|
|
|
|
|
|
|
Paid by us
|
|
Per note
|
|
|
0.650
|
%
|
Total
|
|
$
|
1,950,000
|
|
We estimate our
out-of-pocket expenses associated with this offering, other than the underwriting discount, will be approximately $750,000.
We have also agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as
amended, or to contribute to payments which the underwriters may be required to make in respect of any such liabilities.
The
notes are a new issue of securities, and there is currently no established trading market for the notes. We do not intend to apply for the notes to be listed on any securities exchange or to arrange for the notes to be quoted on any quotation
system. The underwriters have advised us that they intend to make a market in the notes, but they are not obligated to do so. The underwriters may discontinue any market making in the notes at any time at their sole discretion. Accordingly, we
cannot assure you that a liquid trading market will develop for the notes, that you will be able to sell your notes at a particular time or that the prices you receive when you sell will be favorable.
In connection with the offering of the notes, the underwriters may engage in transactions that stabilize, maintain or otherwise affect
the price of the notes. Specifically, the underwriters may overallot in connection
S-20
with the offering of the notes, creating syndicate short positions. In addition, the underwriters may bid for and purchase notes in the open market to cover syndicate short positions or to
stabilize the price of the notes. Finally, the underwriting syndicate may reclaim selling concessions allowed for distributing the notes in the offering of the notes, if the syndicate repurchases previously distributed notes in syndicate covering
transactions, stabilization transactions or otherwise. Any of these activities may stabilize or maintain the market price of the notes above independent market levels. The underwriters are not required to engage in any of these activities, and may
end any of them at any time.
In relation to each Member State of the European Economic Area which has implemented the
Prospectus Directive, each underwriter has represented and agreed that, with effect from and including the date on which the Prospectus Directive is implemented in that Member State, it has not made and will not make an offer of notes to the public
in that Member State except that it may, with effect from and including such date, make an offer of notes to the public in that Member State at any time:
|
|
|
to legal entities which are authorized or regulated to operate in the financial markets or, if not so authorized or regulated, whose corporate purpose
is solely to invest in securities;
|
|
|
|
to any legal entity which has two or more of (1) an average of at least 250 employees during the last financial year; (2) a total balance
sheet of more than 43,000,000; and (3) an annual net turnover of more than 50,000,000, as shown in its last annual or consolidated accounts;
|
|
|
|
to fewer than 100 natural or legal persons (other than qualified investors as defined in the Prospectus Directive) subject to obtaining the prior
consent of the representatives for any such offer; or
|
|
|
|
in any other circumstances which do not require the publication by us of a prospectus pursuant to Article 3 of the Prospectus Directive.
|
For the purposes of the above, the expression an offer of notes to the public in relation to
any notes in any Member State means the communication in any form and by any means of sufficient information on the terms of the offer and the notes to be offered so as to enable an investor to decide to purchase or subscribe for the notes, as the
same may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State, and the expression Prospectus Directive means Directive 2003/717I/EC and includes any relevant implementing measure in that Member
State.
Each underwriter has represented and agreed that (a) it has only communicated or caused to be communicated and
will only communicate or cause to be communicated an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Act 2000 (the Act)) in connection with the issue
or sale of the notes in circumstances in which Section 21(1) of such Act does not apply to us and (b) it has complied and will comply with all applicable provisions of such Act with respect to anything done by it in relation to any notes
in, from or otherwise involving the United Kingdom.
From time to time in the ordinary course of their respective businesses,
certain of the underwriters and their affiliates have engaged in and may in the future engage in commercial banking, derivatives and/or financial advisory, investment banking and other commercial transactions and services with us and our affiliates
for which they have received or will receive customary fees and commissions.
In addition, in the ordinary course of their
business activities, the underwriters and their affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own
account and for the accounts of their customers. Such investments and securities activities may involve securities and/or instruments of ours or our affiliates. The underwriters and their affiliates may also make investment recommendations and/or
publish or express independent research views in respect of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments.
S-21
LEGAL MATTERS
The validity of the notes will be passed upon for us by Bryan Cave LLP, St. Louis, Missouri. Certain legal matters, including the validity of the notes, will be passed upon for the underwriters by
Shearman & Sterling LLP, New York, New York.
EXPERTS
The consolidated financial statements of Sigma-Aldrich Corporation as of December 31, 2009 and 2008, and for each of the years in the
three-year period ended December 31, 2009, and managements assessment of the effectiveness of internal control over financial reporting as of December 31, 2009 have been incorporated herein and in the registration statement in reliance upon
the report of KPMG LLP, independent registered public accounting firm, incorporated herein and in the registration statement, and upon the authority of said firm as experts in auditing and accounting. The report of KPMG LLP refers to the
companys adoption of an interpretation of Statement of Financial Accounting Standards No. 109 (ASC 740) effective January 1, 2007.
S-22
PROSPECTUS
SIGMA-ALDRICH CORPORATION
Debt Securities
Common Stock
Warrants
Purchase Contracts
Units
We may offer
and sell from time to time our securities in one or more classes, separately or together in any combination and as separate series, and in amounts, at prices and on terms that we will determine at the times of the offerings. Selling security holders
to be named in a prospectus supplement may offer and sell from time to time securities in such amounts as set forth in a prospectus supplement. Unless otherwise set forth in a prospectus supplement, we will not receive any proceeds from the sale of
such securities by any selling security holders.
This prospectus provides you with a general description of the securities.
We will provide specific terms of any offering in a prospectus supplement or term sheet. The prospectus supplement or term sheet may also add, update or change information contained in this prospectus.
We or any selling security holder may offer the securities independently or together in any combination for sale directly to purchasers
or through underwriters, dealers or agents to be designated at a future date. The supplements to this prospectus will provide the specific terms of the plan of distribution.
This prospectus may not be used to sell securities unless accompanied by a prospectus supplement or a free writing prospectus.
Our common stock is traded in the National Association of Securities Dealers Automated Quotation System (NASDAQ) Global Select Market under the symbol SIAL.
Investing in our securities involves risk. See
Risk Factors
beginning on page 1 of this
prospectus.
Neither the Securities and Exchange Commission nor any state securities commission has approved or
disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.
The date of
this prospectus is October 25, 2010
TABLE OF CONTENTS
ABOUT THIS PROSPECTUS
This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission, or SEC, using a shelf registration process. Under this shelf process, we may,
from time to time, sell the securities or combinations of the securities described in this prospectus in one or more offerings. For further information about our business and the securities, you should refer to the registration statement and its
exhibits. The exhibits to our registration statement contain the full text of certain contracts and other important documents we have summarized in this prospectus. Since these summaries may not contain all the information that you may find
important in deciding whether to purchase the securities we offer, you should review the full text of these documents. The registration statement and the exhibits can be obtained from the SEC as indicated under the heading Where You Can Find
More Information.
This prospectus provides you with a general description of the securities that we or selling security
holders may offer. Each time we or such security holders offer securities, we will provide a prospectus supplement and/or other offering material that will contain specific information about the terms of that offering. The prospectus supplement may
also add, update or change information contained in this prospectus. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement, you should rely on the information in the prospectus supplement.
You should read this prospectus and any prospectus supplement together with additional information described under the heading Where You Can Find More Information.
You should rely only on the information provided in this prospectus, in any prospectus supplement, or any other offering material that we authorize, including the information incorporated by reference. We
have not authorized anyone to provide you with different information. You should not assume that the information in this prospectus, any supplement to this prospectus, or any other offering material that we authorize, is accurate at any date other
than the date indicated on the cover page of these documents or the date of the statement contained in any incorporated documents, respectively. This prospectus is not an offer to sell or a solicitation of an offer to buy any securities other than
the securities referred to in the prospectus supplement. This prospectus is not an offer to sell or a solicitation of an offer to buy such securities in any circumstances in which such offer or solicitation is unlawful. You should not interpret the
delivery of this prospectus, or any sale of securities, as an indication that there has been no change in our affairs since the date of this prospectus. You should also be aware that information in this prospectus may change after this date.
Unless the context otherwise requires, in this prospectus Sigma-Aldrich, Company, we,
us, our and ours refer to Sigma-Aldrich Corporation and its consolidated subsidiaries.
RISK FACTORS
Investing in our securities involves risks. You should carefully consider the risks described under
Risk Factors in Item 1A of the Companys Annual Report on Form 10-K for the year ended December 31, 2009, in our Current Report on Form 8-K filed October 25, 2010, and in the other documents incorporated by reference into
this prospectus (which risk factors are incorporated by reference herein), as well as the other information contained or incorporated by reference in this prospectus or in any prospectus supplement hereto before making a decision to invest in our
securities. See Where You Can Find More Information.
SIGMA-ALDRICH CORPORATION
Sigma-Aldrich Corporation is a leading Life Science and High Technology company. We develop, manufacture, purchase and
distribute the broadest range of high quality chemicals, biochemicals and equipment available throughout the world. These chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology,
pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. We operate in 40 countries, manufacturing
1
approximately 48,000 of the 130,000 chemical products we offer. We also offer approximately 40,000 equipment products. We sell into over 160 countries, servicing over 92,000 accounts representing
over one million individual customers. Our principal executive offices are located at 3050 Spruce Street, St. Louis, Missouri 63103. Our telephone number is 314-771-5765.
WHERE YOU CAN FIND MORE INFORMATION
We file
annual, quarterly and current reports, proxy statements and other information with the SEC. You may read and copy any document we file at the SECs Public Reference Room, 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at
1-800-SEC-0330 for further information on their public reference room. Our SEC filings are also available to the public at the SECs website at http://www.sec.gov. Our common stock is listed and traded in the National Association of Securities
Dealers Automated Quotation System (NASDAQ) Global Select Market. Information about us, including our SEC filings, is also available at our Internet site at http://www.sigma-aldrich.com. However, the information on our Internet site is
not a part of this prospectus or any prospectus supplement.
The SEC allows us to incorporate by reference
information into this prospectus. This means that we can disclose important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference is considered to be a part of this
prospectus, and later information that we file with the SEC will automatically update and supersede this information. We incorporate by reference the documents listed below and any future filings made with the SEC under Section 13(a), 13(c), 14
or 15(d) of the Securities Exchange Act of 1934, as amended, which we refer to as Exchange Act (other than those made pursuant to Item 2.02 or Item 7.01 of Form 8-K or other information furnished to the SEC) after
the date of this prospectus and before the end of the offering of the securities pursuant to this prospectus (SEC File No. 000-08135):
|
|
|
our Annual Report on Form 10-K for the fiscal year ended December 31, 2009, filed with the SEC on February 10, 2010;
|
|
|
|
our Definitive Proxy Statement on Schedule 14A, filed with the SEC on March 15, 2010;
|
|
|
|
our Quarterly Reports on Form 10-Q for the quarterly period ended March 31, 2010, filed with the SEC on April 22, 2010; for the quarterly
period ended June 30, 2010, filed with the SEC on July 22, 2010, as amended pursuant to Form 10-Q/A filed with the SEC on July 28, 2010; and for the quarterly period ended September 30, 2010, filed with the SEC on
October 21, 2010;
|
|
|
|
our Current Reports on Form 8-K, filed with the SEC on May 6, 2010; May 18, 2010 and October 25, 2010; and
|
|
|
|
the description of our common stock contained in our Current Report on Form 8-K, filed with the SEC on October 25, 2010.
|
We encourage you to read our periodic and current reports, as they provide additional information about us
which prudent investors find important. All of these documents are also available at no charge upon request sent to Sigma-Aldrich Corporation, Attn: Corporate Secretary, 3050 Spruce Street, St. Louis, Missouri 63103, telephone: (314) 771-5765.
2
SELLING SECURITY HOLDERS
We may register securities covered by this prospectus for re-offers and resales by any selling security holders to be named in a prospectus supplement. Because we are a well-known seasoned issuer, as
defined in Rule 405 of the Securities Act of 1933, which we refer to as the Securities Act, we may add secondary sales of securities by any selling security holders by filing a prospectus supplement with the SEC. We may register these
securities to permit selling security holders to resell their securities when they deem appropriate. A selling security holder may resell all, a portion or none of such security holders securities at any time and from time to time. Selling
security holders may also sell, transfer or otherwise dispose of some or all of their securities in transactions exempt from the registration requirements of the Securities Act. We do not know when or in what amounts any selling security holders may
offer securities for sale under this prospectus and any prospectus supplement. We may pay some or all expenses incurred with respect to the registration of the securities owned by the selling security holders. We will provide a prospectus supplement
naming any selling security holders, the amount of securities to be registered and sold and any other terms of securities being sold by each selling security holder.
USE OF PROCEEDS
Unless we specify another use
in the applicable prospectus supplement, we will use the net proceeds from the sale of any securities offered by us for general corporate purposes. Such general corporate purposes may include working capital, investments in or extensions of credit
to our subsidiaries, capital expenditures, stock repurchases, debt repayment or financing for acquisitions. Pending such use, the proceeds may be invested temporarily in short-term, interest-bearing, investment-grade securities or similar assets.
Except as may otherwise be specified in the applicable prospectus supplement, we will not receive any proceeds form any sales of securities by any selling security holder.
RATIO OF EARNINGS TO FIXED CHARGES
The
following table sets forth the ratio of earnings to fixed charges for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended
September 30,
|
|
|
Twelve months
ended
December 31,
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
Ratio of earnings to fixed charges
|
|
|
19.9
|
|
|
|
17.1
|
|
|
|
13.8
|
|
|
|
10.6
|
|
|
|
9.3
|
|
|
|
10.3
|
|
Earnings consist
principally of income from continuing operations before income taxes, plus fixed charges. Fixed charges include interest expense, the portion of rent expense representative of interest and capitalized interest.
As of the date of this prospectus, we have no preferred stock outstanding.
CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS
This prospectus and the documents incorporated by reference in the prospectus contain forward-looking statements within the meaning of
Section 27A of the Securities Act and Section 21E of the Exchange Act that involve risk and uncertainty, including financial, business environment and projections, as well as statements that are preceded by, followed by, or that include
the words believes, expects, anticipates, should or similar expressions, and other statements contained herein regarding matters that are not historical facts. Additionally, this prospectus and the
documents incorporated by reference in the prospectus contain forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs, including without limitation, statements regarding
our expectations, goals, beliefs, intentions and the like regarding future sales, earnings, restructuring charges, cost savings, process improvements, share repurchases, capital expenditures, acquisitions and other matters. These statements involve
assumptions regarding our operations, investments, acquisitions and conditions in the markets we serve.
3
Although we believe
our expectations are based on reasonable assumptions, such statements are subject to risks and uncertainties, including, among others, certain economic, political and technological factors. Actual results could differ materially from those stated or
implied in this document and the documents incorporated in it, due to, but not limited to, such factors as:
|
|
|
global economic conditions;
|
|
|
|
changes in pricing and the competitive environment and the global demand for our products;
|
|
|
|
fluctuations in foreign currency exchange rates;
|
|
|
|
changes in research funding and the success of research and development activities;
|
|
|
|
dependence on uninterrupted manufacturing operations;
|
|
|
|
changes in the regulatory environment in which we operate;
|
|
|
|
changes in worldwide tax rates or tax benefits from domestic and international operations, including the matters described in Note 3 of our Quarterly
Report on Form 10-Q for the quarter ended September 30, 2010 and in Note 10 to the Consolidated Financial Statements in our Form 10-K for the year ended December 31, 2009;
|
|
|
|
exposure to litigation, including product liability claims;
|
|
|
|
the ability to maintain adequate quality standards;
|
|
|
|
reliance on third party package delivery services;
|
|
|
|
failure to achieve planned cost reductions in global supply chain initiatives and restructuring actions;
|
|
|
|
an unanticipated increase in interest rates;
|
|
|
|
failure of planned sales initiatives in our Research and SAFC businesses;
|
|
|
|
other changes in the business environment in which the Company operates;
|
|
|
|
the outcome of the outstanding matters described in the Companys Quarterly Report on Form 10-Q for the period ended September 30, 2010 under
Part IItem 2. Managements Discussion and Analysis of Financial Condition and Results of OperationsOther Matters; and
|
|
|
|
the matters referred to under Risk Factors above.
|
These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements included in
this document. These risks and uncertainties, as well as other risks of which we are not aware or which we currently do not believe to be material, may cause our actual future results to be materially different than those expressed in our
forward-looking statements. We do not undertake to update our forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.
4
DESCRIPTION OF DEBT SECURITIES
The debt securities will be our senior unsecured debt securities. The following description of the terms of the debt securities sets
forth general terms that may apply to the debt securities. The particular terms of any debt securities will be described in the prospectus supplement relating to those debt securities. For purposes of this description of debt securities, the terms
we, our, ours, and us refer only to Sigma-Aldrich Corporation and not to any of its subsidiaries.
The Indenture
The debt securities will be issued in one or more series
under an indenture (the Indenture or an indenture), between us and Deutsche Bank Trust Company Americas, as trustee. The statements herein relating to the debt securities and the indenture are summaries and are subject to the
detailed provisions of the indenture. The indenture will be subject to and governed by the Trust Indenture Act of 1939. The description below is a summary and does not contain all the information you may find useful. We urge you to read the
indenture because it, and not this summary, defines many of your rights as a holder of our debt securities. The form of the indenture has been incorporated by reference as an exhibit to the registration statement of which this prospectus is a part.
If you would like to read the indenture, it is on file with the SEC, as described under Where You Can Find More Information. Whenever we refer to particular sections or defined terms in an indenture, those sections and definitions are
incorporated by reference.
General
The indenture does not limit the aggregate amount of debt securities which we may issue nor does it limit other debt we may issue. We may issue senior or subordinated debt securities under the indenture
up to the aggregate principal amount authorized by our board of directors from time to time. Except as may be described in a prospectus supplement, the indenture will not limit the amount of other secured or unsecured debt that we may incur or
issue.
The senior debt securities will rank equally with all our other unsubordinated obligations. The indenture will provide
that the debt securities may be issued from time to time in one or more series. Unless otherwise provided, all debt securities of any one series may be reopened for issuance of additional debt securities of such series. (Section 3.1 of the
indenture). We may authorize the issuance and provide for the terms of a series of debt securities pursuant to a supplemental indenture.
The indenture will place no limitation on the amount of additional secured indebtedness that we may incur. We expect from time to time to incur additional indebtedness constituting secured indebtedness.
Our outstanding secured indebtedness would rank senior to our senior unsecured indebtedness to the extent of such security, and our outstanding short- and long-term indebtedness would rank equally with our senior unsecured debt securities.
The applicable prospectus supplement relating to the particular series of debt securities will describe specific terms of the
debt securities offered thereby, including, where applicable:
|
|
|
the title and any limit on the aggregate principal amount of the debt securities and whether the debt securities will be senior or subordinated;
|
|
|
|
the price at which we are offering the debt securities, usually expressed as a percentage of the principal amount;
|
|
|
|
the date or dates on which the debt securities of a series will be issued, and on which the principal of and any premium on such debt securities, or
any installments thereof, will mature or the method of determining such date or dates;
|
5
|
|
|
the rate or rates, which may be fixed or variable at which such debt securities will bear interest or the method of calculating such rate or rates, if
any;
|
|
|
|
the date or dates from which any interest will accrue or the method of determining such dates;
|
|
|
|
the date or dates on which any interest will be payable and the applicable record dates;
|
|
|
|
the place or places where principal of, premium, if any, and interest, if any, on such debt securities, or installments thereof, if any, will be
payable;
|
|
|
|
any of our obligations to redeem, repay, purchase or offer to purchase the debt securities pursuant to any mandatory redemption, sinking fund or
analogous provisions or upon other conditions or at the option of the holders of the debt securities and the periods, prices and the other terms and conditions of such redemption or repurchase, in whole or in part;
|
|
|
|
any of our right to redeem the debt securities at our option and the periods, prices and the other terms and conditions of such redemption, in whole or
in part;
|
|
|
|
the denominations in which such debt securities will be issued;
|
|
|
|
if other than U.S. dollars, the currency or currencies in which the debt securities are denominated and/or payable;
|
|
|
|
whether the debt securities are original issue discount securities (as described below under Original Issue Discount Securities) and
the amount of discount;
|
|
|
|
the provisions for payment of additional amounts or tax redemptions, if any;
|
|
|
|
any addition to, or modification or deletion of, any event of default or covenant specified in the indenture with respect to such debt securities;
|
|
|
|
whether the debt securities of the series shall be issued in whole or in part in certified form;
|
|
|
|
the designation, if any, of any depositaries, trustees, paying agents, authenticating agents, security registrars or other agents with respect to the
debt securities of such series;
|
|
|
|
any terms upon which the holders may convert or exchange debt securities into or for our common stock or other securities or property of us or another
issuer;
|
|
|
|
if other than the entire principal amount, the portion of the principal amount of debt securities which becomes payable upon a declaration of
acceleration of maturity or the method of determining such portion;
|
|
|
|
material federal income tax considerations, if applicable; and
|
|
|
|
any other special terms pertaining to such debt securities. (Section 3.1 of the indenture).
|
Unless otherwise specified in the applicable prospectus supplement, the debt securities will not be listed on any securities exchange or
included in any market.
None of our stockholders, officers or directors, past, present or future, will have any personal
liability with respect to our obligations under the indenture or debt securities on account of that status. (Section 1.13 of the indenture).
Debt securities may also be issued pursuant to the indenture in transactions exempt from the registration requirements of the Securities Act. Those debt securities will not be considered in determining
the amount of securities issued under this registration statement.
6
Form and Denominations
Unless we specify otherwise in the applicable prospectus supplement, debt securities will be issued only in fully
registered form, without coupons, and will be denominated in U.S. dollars issued only in minimum denominations of U.S. $2,000 and any integral multiple of $1,000 in excess thereof. (Section 3.2 of the indenture).
Original Issue Discount Securities
Debt securities may be sold at a substantial discount below their stated principal amount and may bear no interest or interest at a rate which at the time of issuance is below market rates. Important
federal income tax consequences and special considerations applicable to any such debt securities will be described in the applicable prospectus supplement.
Indexed Securities
If the amount of payments of principal of, and
premium, if any, or any interest on, debt securities of any series is determined with reference to any type of index or formula or changes in prices of particular securities or commodities, the federal income tax consequences, specific terms and
other information with respect to such debt securities and such index or formula and securities or commodities will be described in the applicable prospectus supplement.
Conversion and Exchange
If any debt securities are convertible into or
exchangeable for other securities, the prospectus supplement or term sheet will explain the terms and conditions of the conversion or exchange, including the conversion or exchange price or rate (or the calculation method), the conversion or
exchange period (or how the period will be determined), if conversion or exchange will be mandatory or at the option of the holder or us, provisions for adjusting the conversion or exchange price or rate and provisions affecting conversion or
exchange in the event of the redemption of the underlying debt securities. These terms may also include provisions under which the number or amount of other securities to be received by the holders of the debt securities upon conversion or exchange
would be calculated according to the market price of the other securities as of a time stated in the prospectus supplement or term sheet.
Payment
Unless we
specify otherwise in the applicable prospectus supplement:
|
|
|
payments in respect of the debt securities will be made at the corporate trust office of the trustee, except that, at our option interest payments on
debt securities in registered form may be made by checks mailed to the holders of debt securities entitled to payments at their registered addresses or, if provided in the applicable prospectus supplement, by wire transfer to an account designated
by the registered holder; and
|
|
|
|
payment of any installment of interest on debt securities in registered form will be made to the person in whose name such debt security is registered
at the close of business on the regular record date for such interest. (Section 3.7 of the indenture).
|
If
we do not pay interest when due, that interest will no longer be payable to the registered holder of the debt security on the record date for such interest. We will pay any defaulted interest, at our election:
|
|
|
to the person in whose name the debt security is registered at the close of business on a special record date set by the trustee between 1015
days before the payment of such defaulted interest and at least 10 days after the receipt by the trustee of notice of the proposed payment by us; or
|
7
|
|
|
in any other lawful manner that is consistent with the requirements of any securities exchange, if any, on which the debt securities are listed if,
after we give notice to the trustee, the trustee determines that the manner of payment is practicable. (Section 3.7 of the indenture).
|
Registration, Transfer and Exchange
Unless we specify otherwise in the
applicable prospectus supplement, debt securities in registered form will be transferable or exchangeable at the agency maintained for such purpose we designate from time to time. Debt securities may be transferred or exchanged generally without
service charge, other than any tax or other governmental charge imposed in connection with such transfer or exchange. (Section 3.5 of the indenture). We intend to appoint the trustee under the indenture as security registrar with respect to
securities issued under the indenture.
Unless we specify otherwise in the applicable prospectus supplement, we will not be
required (i) to register, transfer or exchange any debt securities during a period beginning at the opening of business 15 days before the day of the transmission of a notice of redemption of such debt securities to be redeemed and ending at
the close of business on the day of such transmission, or (ii) to register, transfer or exchange any debt security to be redeemed in whole or in part, except the unredeemed portion of any debt security being redeemed in part.
Consolidation, Merger, Conveyance, Sale of Assets and Other Transfers
We may not consolidate with or merge with or into, whether or not we are the surviving corporation, or sell, assign, convey, transfer or lease our properties and assets substantially as an entirety to any
person, unless:
|
|
|
the surviving corporation or the person acquiring the assets is organized and existing under the laws of the United States or one of the 50 states, any
U.S. territory or the District of Columbia, and assumes the obligation to pay the principal of, and premium, if any, and interest on all the debt securities, and to perform or observe all covenants of the indenture;
|
|
|
|
immediately after the transaction, there is no event of default under the indenture; and
|
|
|
|
we deliver to the trustee a certificate and opinion of counsel stating that the transaction complies with the indenture. (Section 10.1 of the
indenture).
|
Upon the consolidation, merger or sale, the successor corporation formed by the consolidation,
or into which we are merged or to which the sale is made, will succeed to, and be substituted for us under the indenture. (Section 10.2 of the indenture).
Unless we specify otherwise in the applicable prospectus supplement, the indenture and the terms of the debt securities will not contain any covenants designed to afford holders of any debt securities
protection in a highly leveraged or other transaction involving us, whether or not resulting in a change of control, which may adversely affect holders of the debt securities.
Restrictions on Liens
Unless otherwise provided in the applicable
prospectus supplement, we will not, and will not permit any of our Restricted Subsidiaries to, create, incur, issue, assume or guarantee any indebtedness for money borrowed secured by a Lien (Secured Debt) upon any Principal Property or
any shares of stock or indebtedness for borrowed money of any Restricted Subsidiary, whether owned at the date of the indenture or thereafter acquired, without effectively providing concurrently that the debt securities are secured equally and
ratably with or, at our option, prior to such Secured Debt so long as such Secured Debt shall be so secured.
8
The foregoing
restriction shall not apply to, and there shall be excluded from Secured Debt in any computation under such restriction, Secured Debt secured by:
(1) Liens on any property, shares of stock or indebtedness for borrowed money of any entity existing at the time such entity becomes a Restricted Subsidiary;
(2) Liens on property or shares of stock existing at the time of the acquisition of such property or stock by us or a
Restricted Subsidiary, or existing as of the original date of the indenture;
(3) Liens to secure the payment
of all or any part of the price of acquisition, construction or improvement of such property or stock by us or a Restricted Subsidiary, or to secure any Secured Debt incurred by us or a Restricted Subsidiary, prior to, at the time of, or within 360
days after, the later of the acquisition or completion of construction (including any improvements on an existing property), which Secured Debt is incurred for the purpose of financing all or any part of the purchase price thereof or construction of
improvements thereon
;
provided
,
however
, that, in the case of any such acquisition, construction or improvement, the Lien shall not apply to any property theretofore owned by us or a Restricted Subsidiary, other than, in the
case of any such construction or improvement, any theretofore substantially unimproved real property on which the property or improvement so constructed is located;
(4) Liens securing Secured Debt of a Restricted Subsidiary owing to us or to another Restricted Subsidiary;
(5) Liens on property of an entity existing at the time such entity is merged into or consolidated with us or a
Restricted Subsidiary or at the time of a sale, lease or other disposition of the properties of an entity as an entirety or substantially as an entirety to us or a Restricted Subsidiary;
(6) Liens on our or Restricted Subsidiarys property in favor of the United States or any state thereof, or any
department, agency or instrumentality or political subdivision of the United States or any state thereof, or in favor of any other country or any political subdivision thereof, or any department, agency or instrumentality of such country or
political subdivision, to secure partial progress, advance or other payments pursuant to any contract or statute or to secure any indebtedness incurred for the purpose of financing all or any part of the purchase price or the cost of construction of
the property subject to such Liens;
(7) Liens upon any Principal Property, or any transfer or disposition of
any Principal Property, that is created or implemented as a necessary component of a bond for title transaction, payment in lieu of tax agreement or other tax incentive vehicle designed to provide us or any Subsidiary with certain ad valorem
property tax savings or other incentive savings;
(8)
Liens incurred or assumed in connection with the
issuance of revenue bonds the interest on which is exempt from federal taxation pursuant to Section 103 of the Internal Revenue Code
;
(9) Liens to secure Hedging Obligations entered into in the ordinary course of business to purchase any raw material or other commodity or to hedge risks or reduce costs with respect to our, or any of our
Restricted Subsidiaries, interest rate, currency or commodity exposure, and not for speculative purposes;
(10) Any extension, renewal or replacement (or successive extensions, renewals or replacements) in whole or in part of
any Lien referred to in clauses (1) through (9) above;
provided
,
however
, that the principal amount of Secured Debt so secured shall not exceed the principal amount of Secured Debt so secured at the time of such extension,
renewal or replacement (except any amounts committed at the date of the indenture), and that such extension, renewal or replacement shall be limited to all or a part of the property which secured the Lien so extended, renewed or replaced (plus
improvements and construction on such property).
9
Notwithstanding the
foregoing, we and any one or more of our Restricted Subsidiaries may, however, without securing any debt securities, create, incur, issue, assume or guarantee Secured Debt secured by a Lien if, after giving effect to the transaction, the aggregate
of the Secured Debt then outstanding (not including Secured Debt permitted under the above exceptions) does not exceed 15% of our Consolidated Net Tangible Assets as shown on our consolidated financial statements as of the end of the fiscal year
preceding the date of determination. (Section 12.5 of the indenture).
Commodity Agreement means any forward
contract, commodity swap, commodity option or other financial agreement or arrangement relating to, or the value of which is dependent upon, fluctuations in commodity prices.
Consolidated Net Tangible Assets means our and our Restricted Subsidiaries total assets (including, without limitation, any net investments in Subsidiaries that are not Restricted
Subsidiaries) after deducting therefrom (a) all current liabilities (excluding any notes and loans payable, current maturities of long-term debt, the current portion of deferred revenue, obligations under capital leases and any other liability
constituting indebtedness for borrowed money) and (b) all goodwill, trade names, trademarks, franchises, patents, unamortized debt discount and expense, organization and developmental expenses and other like segregated intangibles, all as
computed by Sigma-Aldrich and its Restricted Subsidiaries as of the end of the fiscal year preceding the date of determination in accordance with GAAP;
provided
, that any items constituting deferred income taxes, deferred investment tax
credit or other similar items shall not be taken into account as a liability or as a deduction from or adjustment to total assets.
Currency Agreement means any foreign exchange contract, currency swap agreement or other similar agreement with respect to currency values.
GAAP means U.S. generally accepted accounting principles set forth in the opinions and pronouncements of the Financial
Accounting Standards Board and in opinions of the Accounting Principles Board of the American Institute of Certified Public Accountants or in such other statements by such other entity as have been approved by a significant segment of the accounting
profession
or which have other substantial authoritative support in the United States and are applicable in the circumstances, in each case, as applied on a consistent basis, which are in effect as of the issuance date of the Debt
Securities.
Hedging Obligations of any Person means the obligations of such Person pursuant to any
Interest Rate Agreement, Currency Agreement, Commodity Agreement or derivative contract entered into to hedge interest rate risk, currency exchange risk, and commodity price risk.
Interest Rate Agreement means any interest rate swap agreement, interest rate cap agreement or other financial agreement or
arrangement with respect to exposure to interest rates.
Lien or Liens means any mortgage, pledge,
lien, security interest or other encumbrances upon any Principal Property or any shares of stock or on indebtedness for borrowed money of any Restricted Subsidiary (whether such Principal Property, shares of stock or indebtedness for borrowed money
are now owned or hereafter acquired).
Person means any individual, corporation, partnership, joint venture,
trust, unincorporated organization or government or any agency or political subdivision thereof.
Principal
Property means each plant or facility of ours or a Restricted Subsidiary located within the United States of America (other than its territories and possessions) or Puerto Rico, except any such plant or facility which either (i) has a
gross book value of less than 2% of Consolidated Net Tangible Assets or (ii) in the good faith opinion of our board of directors, is not of material importance to the total business conducted by us and our Restricted Subsidiaries.
10
Restricted
Subsidiary means any of our Subsidiaries: (i) substantially all of the property of which is located, or substantially all of the business of which is carried on, within the United States of America, the District of Columbia, or Puerto
Rico and (ii) which owns or is the lessee of any Principal Property.
Subsidiary means (1) any
corporation of which at least a majority of the outstanding stock having by the terms thereof ordinary voting power for the election of directors of such corporation (irrespective of whether or not at the time stock of any other class or classes of
such corporation shall have or might have voting power by reason of the happening of any contingency) is at the time directly or indirectly owned by us or one or more other Subsidiaries and (2) any other Person in which we or one or more other
Subsidiaries, directly or indirectly, at the date of determination, (x) own at least a majority of the outstanding ownership interests or (y) have the power to elect or direct the election of, or to appoint or approve the appointment of,
at least the majority of the directors, trustees or managing members of, or other persons holding similar positions with, such Person.
Restrictions on Sale and Leaseback Transactions.
Unless otherwise provided in the applicable prospectus supplement, we will not, and will not permit any Restricted Subsidiary to, enter into any Sale and Leaseback Transaction unless:
(1) We or such Restricted Subsidiary would be entitled to create, incur, issue, assume or guarantee indebtedness secured
by a Lien upon such property at least equal in amount to the Attributable Debt in respect of such arrangement without equally and ratably securing the debt securities;
provided
,
however
, that from and after the date on which such
arrangement becomes effective, the Attributable Debt in respect of such arrangement shall be deemed, for all purposes described under Restrictions on Liens above, to be Secured Debt subject to the provisions of the covenants
described therein; or
(2) Since the original date of the indenture and within a period commencing twelve
months prior to the consummation of such Sale and Leaseback Transaction and ending twelve months after the consummation of such Sale and Leaseback Transaction, we, or any Restricted Subsidiary, as the case may be, has expended or will expend for the
Principal Property an amount equal to
(A) the net proceeds of such Sale and Leaseback Transaction, and we
elect to designate such amount as a credit against such Sale and Leaseback Transaction, or
(B) a part of the
net proceeds of such Sale and Leaseback Transaction and we elect to designate such amount as a credit against such Sale and Leaseback Transaction and applies an amount equal to the remainder of the net proceeds as provided in the following
paragraph; or
(3) such Sale and Leaseback Transaction does not come within the exceptions provided by the
first paragraph above under Restrictions on Sale and Leaseback Transactions and we do not make the election permitted by the second paragraph under Restrictions on Sale and Leaseback Transactions or make such
election only as to a part of such net proceeds, in either of which events we shall apply an amount in cash equal to the Attributable Debt in respect of such arrangement (less any amount elected under the second paragraph under
Restrictions on Sale and Leaseback Transactions) to the retirement, within 360 days of the effective date of any such arrangement, of indebtedness for borrowed money of ours or any Restricted Subsidiary (other than our indebtedness
for borrowed money which is subordinated to the debt securities) which by its terms matures at or is extendible or renewable at the sole option of the obligor without requiring the consent of the obligees to a date more than twelve months after the
date of the creation of such indebtedness for borrowed money (it being understood that such retirement may be made by prepayment of such indebtedness for borrowed money, if permitted by the terms thereof, as well as by payment at maturity, and that
at our option and pursuant to the terms of the indenture, such indebtedness may include the debt securities). (Section 12.6 of the indenture).
11
Attributable
Debt means the present value (discounted at the weighted average interest rate borne by the debt securities outstanding at the time of such Sale and Leaseback transaction compounded semiannually) of the obligation of a lessee for net rental
payments during the remaining term of any lease (including any period for which such lease has been extended).
Sale and
Leaseback Transaction means any arrangement with any person providing for the leasing by us or any Restricted Subsidiary of any Principal Property, whether such Principal Property is now owned or hereafter acquired (except for
(1) temporary leases for a term, including renewals at the option of the lessee, of not more than three years and (2) leases between us and a Restricted Subsidiary or between Restricted Subsidiaries), which property has been or is to be
sold or transferred by us or such Restricted Subsidiary to such person with the intention of taking back a lease of such property.
Modification or Amendment of the Indenture
Supplemental Indentures with Consent of Holders
. If we receive the consent of the holders of at least a majority in principal amount of the debt securities then outstanding affected thereby, we may
enter into supplemental indentures with the trustee for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of the indenture or modifying in any manner the rights of the holders under the indenture
of such debt securities.
However, unless we receive the consent of all of the affected holders, we may not enter into
supplemental indentures that would, with respect to the debt securities of such holders:
|
|
|
conflict with the required provisions of the Trust Indenture Act;
|
|
|
|
except as described in any prospectus supplement:
|
|
|
|
change the stated maturity of the principal of, or any installment of interest on, any debt security,
|
|
|
|
reduce the principal amount, interest or any premium payable upon redemption; provided, however, that a requirement to offer to repurchase debt
securities will not be deemed a redemption for this purpose,
|
|
|
|
change the currency or currencies in which the principal of, any premium or interest on such debt security is denominated or payable,
|
|
|
|
reduce the amount of the principal of a discount security that would be due and payable upon a declaration of acceleration of the maturity or reduce
the amount of, or postpone the date fixed for, any payment under any sinking fund or analogous provisions of any debt security,
|
|
|
|
impair the right to institute suit for the enforcement of any payment on or after the stated maturity date, or, in the case of redemption, on or after
the redemption date,
|
|
|
|
limit our obligation to maintain a paying agency outside the United States for payment on bearer securities, or
|
|
|
|
adversely affect the right to convert any debt security into shares of our common stock if so provided;
|
|
|
|
reduce the requirement for majority approval of supplemental indentures, or for waiver of compliance with certain provisions of the indenture or
certain defaults; or
|
12
|
|
|
modify any provisions of the indenture relating to waiver of past defaults with respect to that series, except to increase any such percentage or to
provide that certain other provisions of the indenture cannot be modified or waived without the consent of the holders of each such debt security of each series affected thereby. (Section 11.2 of the indenture).
|
Supplemental Indentures Without Consent of Holders.
Without the consent of any holders, we and the trustee may enter into one or
more supplemental indentures for certain purposes, including:
|
|
|
to evidence the succession of another corporation to our rights and covenants in the indenture;
|
|
|
|
to add to our covenants for the benefit of all or any series of debt securities, or to surrender any of our rights or powers conferred in the
indenture;
|
|
|
|
to add any additional events of default;
|
|
|
|
to change or eliminate any provisions, when there are no outstanding debt securities of any series created before the execution of such supplemental
indenture which is entitled to the benefit of the provisions being changed or eliminated;
|
|
|
|
to provide security for or guarantee of the debt securities;
|
|
|
|
to supplement any of the provisions to permit or facilitate the defeasance and discharge of any series of debt securities as long as such action does
not adversely affect the interests of the holders of the debt securities;
|
|
|
|
to establish the form or terms of debt securities in accordance with the indenture;
|
|
|
|
to provide for the acceptance of the appointment of a successor trustee for any series of debt securities or to provide for or facilitate the
administration of the trusts under the indenture by more than one trustee;
|
|
|
|
to cure any ambiguity, to correct or supplement any provision of the indenture which may be defective or inconsistent with any other provision, to
eliminate any conflict with the Trust Indenture Act or to make any other provisions with respect to matters or questions arising under the indenture which are not inconsistent with any provision of the indenture, as long as any such foregoing action
does not adversely affect the interests of the holders; or
|
|
|
|
to adjust any conversion rights upon a merger of us or a sale by us of substantially all of our assets. (Section 11.1 of the indenture).
|
It is not necessary for holders of the debt securities to approve the particular form of any proposed
supplemental indenture, but it is sufficient if the holders approve the substance thereof. (Section 11.2 of the indenture).
A
supplemental indenture which changes or eliminates any covenant or other provision of the indenture to which it relates with respect to one or more particular series of debt securities, or which modifies the rights of the holders of debt securities
of such series with respect to such covenant or other provision, will be deemed not to affect the rights under the indenture of the holders of debt securities of any other series. (Section 11.2 of the indenture). If the changes contained in a
supplemental indenture are so significant as to involve the offering of a new security, then we will file a new registration statement covering the issuance of such debt securities and containing the revised indenture.
13
Events of Default
Unless we specify otherwise in a prospectus supplement, an event of default with respect to any series of debt securities issued under
the indenture means:
|
|
|
default for 30 days in the payment of any interest on any debt security of such series when due;
|
|
|
|
default in the payment of the principal of, and any premium on, any debt security of such series at maturity;
|
|
|
|
default for 30 days in the deposit of any sinking fund payment when due by the terms of any debt security of such series;
|
|
|
|
default in the performance, or breach, of any covenant or warranty of ours in the debt securities of such series or the indenture for 90 days after we
receive notice from the trustee or the holders of at least 25% in principal amount of the outstanding debt securities of the series;
|
|
|
|
certain events of bankruptcy, insolvency or receivership; or
|
|
|
|
any other events which we specify for that series, which will be indicated in the prospectus supplement for that series. (Section 5.1 of the
indenture).
|
Within 90 days after a default in respect of any series of debt securities, the trustee must
give to the holders of such series notice of all uncured and unwaived defaults by us known to it. However, except in the case of payment default, the trustee may withhold such notice if it determines that such withholding is in the interest of the
holders. (Section 6.2 of the indenture).
If an event of default occurs and is continuing in respect of any outstanding series
of debt securities, the trustee or the holders of at least 25% in principal amount of the outstanding debt securities of that series may declare the applicable principal amount of all of the debt securities of that series to be immediately due and
payable. In addition, at any time after such a declaration of acceleration but before a judgment or decree for payment of the money due has been obtained, the holders of a majority in principal amount of outstanding debt securities of that series
may, subject to specified conditions, rescind and annul such acceleration if all events of default, other than the non-payment of accelerated principal, have been cured or waived as provided in the indenture. (Section 5.2 of the indenture).
Unless we specify otherwise in a prospectus supplement, if an event of default because of certain events of bankruptcy,
insolvency or receivership shall occur and be continuing, then the principal amount of all the debt securities outstanding shall be and become due and payable immediately, without notice or other action by any holder or the trustee, to the full
extent permitted by law. (Section 5.2 of the indenture).
The holders of a majority in principal amount of the outstanding
debt securities of a series, on behalf of the holders of all debt securities of that series, may waive any past default and its consequences, except that they may not waive an uncured default in payment or a default which cannot be waived without
the consent of the holders of all outstanding securities of that series. (Section 5.13 of the indenture).
We must file
annually with the trustee a statement, signed by specified officers, stating whether or not such officers have knowledge of any default under the indenture and, if so, specifying each such default and the nature and status of each such default.
(Section 12.2 of the indenture).
Subject to provisions in the indenture relating to its duties in case of default, the
trustee is not required to take action at the request of any holders of debt securities, unless such holders have offered to the trustee reasonable security or indemnity. (Section 6.3 of the indenture).
14
Subject to
indemnification requirements and other limitations set forth in the indenture, the holders of a majority in principal amount of the outstanding debt securities of any series may direct the time, method and place of conducting proceedings for
remedies available to the trustee, or exercising any trust or power conferred on the trustee, in respect of such series. (Section 5.12 of the indenture).
Defeasance; Satisfaction and Discharge
Legal or Covenant
Defeasance
. The indenture provides that we may be discharged from our obligations with respect to the debt securities of any series, as described below, unless otherwise specified in a prospectus supplement. (Section 15.1 of the indenture).
At our option, we may choose one of the following alternatives:
|
|
|
We may elect to be discharged from any and all of our obligations in respect of the debt securities of any series, except for, among other things,
certain obligations to register the transfer or exchange of debt securities of such series, to replace stolen, lost or mutilated debt securities of such series, and to maintain paying agencies and certain provisions relating to the treatment of
funds held by the trustee for defeasance. We refer to this as legal defeasance.
|
|
|
|
Alternatively, we may decide not to comply with certain restrictive covenants contained in the indenture. Any noncompliance with those covenants will
not constitute a default or an event of default with respect to the debt securities of that series. We refer to this as covenant defeasance.
|
In either case, we will be discharged from our obligations if we deposit with the trustee, in trust, sufficient money and/or U.S. Government Obligations (as referred to below), in the opinion of a
nationally recognized firm of independent public accountants, to pay principal, including any mandatory sinking fund payments, any premium, and interest on the debt securities of that series on the maturity of those payments in accordance with the
terms of the indenture and those debt securities. This discharge may occur only if, among other things, we have delivered to the trustee an opinion of counsel or an Internal Revenue Service ruling which provides that the holders of the debt
securities of that series will not recognize income, gain or loss for U.S. federal income tax purposes as a result of the defeasance. In the case of legal defeasance, such an opinion could not be given absent a change of law after the date of this
prospectus. (Section 15.2 of the indenture).
Covenant Defeasance and Events of Default
. In the event we exercise our
option to effect covenant defeasance with respect to any series of debt securities and the debt securities of that series are declared due and payable because of the occurrence of any event of default, the amount of money and/or U.S. Government
Obligations on deposit with the trustee will be sufficient to pay amounts due on the debt securities of that series on the dates on which installments of interest or principal are due but may not be sufficient to pay amounts due on the debt
securities of that series at the time of the acceleration resulting from the event of default. Depending on the event causing the default, you may not be able to obtain payment of the shortfall.
U.S. Government Obligations generally means securities which are (1) direct obligations of the United States backed by
its full faith and credit, or (2) obligations of a person controlled or supervised by and acting as an agency or instrumentality of the United States, the payment of which is unconditionally guaranteed as a full faith and credit obligation by
the United States, which, in either case, are not callable or redeemable at the option of the issuer thereof, and will also include certain depository receipts. (Section 15.2 of the indenture).
We may exercise our legal defeasance option even if we have already exercised our covenant defeasance option. (Section 15.2 of the
indenture).
Legal defeasance and covenant defeasance are both subject to certain conditions, such as no default or event of
default occurring and continuing, and no breach of any material agreement.
15
Notices to Registered Holders
Notices to registered holders of debt securities will be sent by mail to the addresses of those holders as they appear in
the security register. (Section 1.5 of the indenture).
Replacement of Securities
We will replace any mutilated debt security at the expense of the holder upon surrender of the mutilated debt security to the trustee in
the circumstances described in the indenture. We will replace debt securities that are destroyed, stolen or lost at the expense of the holder upon delivery to the trustee of evidence of the destruction, loss or theft of the debt securities
satisfactory to us and to the trustee in the circumstances described in the indenture. In the case of a destroyed, lost or stolen debt security, an indemnity and/or security satisfactory to the trustee and us, and payment of any taxes, governmental
charges or other expenses, may be required from the holder of the debt security before a replacement debt security will be issued. (Section 3.6 of the indenture).
Governing Law
The indenture and the debt securities will be governed by,
and construed in accordance with, the internal laws of the State of New York. (Section 1.11 of the indenture).
Regarding the Trustee
Deutsche Bank Trust Company Americas will serve as the trustee under the indenture. We and our subsidiaries may maintain
deposits or conduct other banking transactions with the trustee or its affiliates in the ordinary course of business. An affiliate of the trustee is also a lender under our European revolving credit facility due March 13, 2014, under which no
amounts are currently outstanding.
If the trustee is or becomes one of our creditors, the indenture limits the right of the
trustee to obtain payment of claims in certain cases, or to realize on certain property received in respect of any such claims as security or otherwise. The trustee will be permitted to engage in other transactions. However, if after a specified
default has occurred and is continuing, it acquires or has a conflicting interest, it must eliminate such conflict within 90 days or receive permission from the SEC to continue as a trustee or resign.
There may be more than one trustee under the indenture, each with respect to one or more series of debt securities. (Section 1.1 of the
indenture). Any trustee may resign or be removed with respect to one or more series of debt securities, and a successor trustee may be appointed to act with respect to such series. (Section 6.10 of the indenture).
If two or more persons are acting as trustee with respect to different series of debt securities, each trustee will be a trustee of a
trust under the indenture separate from the trust administered by any other such trustee. Except as otherwise indicated in this prospectus or in an applicable prospectus supplement, any action to be taken by the trustee may be taken by each such
trustee with respect to, and only with respect to, the one or more series of debt securities for which it is trustee under the indenture. (Sections 1.1 and 6.10 of the indenture).
Global Debt Securities
Unless we specify otherwise in a prospectus
supplement for a particular series of debt securities, each series of debt securities will be issued in whole or in part in global form and will be deposited with, or on behalf of, a depositary identified in the prospectus supplement relating to
that series. Global securities will be registered in the name of the depositary or its nominee, which will be the sole direct holder of the global securities. Any person wishing to own a debt security must do so indirectly through an account with a
broker, bank or other financial institution that, in turn, has an account with the depositary.
16
Special Investor
Considerations for Global Securities
. Under the terms of the indenture, our obligations with respect to the debt securities, as well as the obligations of the trustee, run only to persons who are registered holders of debt securities. For
example, once we make payment to the registered holder, we have no further responsibility for that payment even if the recipient is legally required to pass the payment along to an individual investor but fails to do so. As an indirect holder, an
investors rights relating to a global security will be governed by the account rules of the investors financial institution and of the depositary, as well as general laws relating to transfers of debt securities.
An investor should be aware that when debt securities are issued in the form of global securities:
|
|
|
the investor cannot have debt securities registered in his or her own name;
|
|
|
|
the investor cannot receive physical certificates for his or her debt securities;
|
|
|
|
the investor must look to his or her bank or brokerage firm for payments on the debt securities and protection of his or her legal rights relating to
the debt securities;
|
|
|
|
the investor may not be able to sell interests in the debt securities to some insurance or other institutions that are required by law to hold the
physical certificates of debt that they own;
|
|
|
|
the depositarys policies will govern payments, transfers, exchanges and other matters relating to the investors interest in the global
security; and
|
|
|
|
the depositary will usually require that interests in a global security be purchased or sold within its system using same-day funds.
|
Neither we nor the trustee has any responsibility for any aspect of the depositarys actions or for
its records of ownership interests in the global security, and neither we nor the trustee supervises the depositary in any way.
Special Situations When the Global Security Will Be Terminated
. In a few special situations described below, the global security
will terminate, and interests in the global security will be exchanged for physical certificates representing debt securities. After that exchange, the investor may choose whether to hold debt securities directly or indirectly through an account at
the investors bank or brokerage firm. In that event, investors must consult their banks or brokers to find out how to have their interests in debt securities transferred to their own names so that they may become direct holders.
The special situations where a global security is terminated are:
|
|
|
when the depositary notifies us that it is unwilling, unable or no longer qualified to continue as depositary, unless a replacement is named;
|
|
|
|
when an event of default on the debt securities has occurred and has not been cured; or
|
|
|
|
when and if we decide (subject to the procedures of the depositary) to terminate a global security. (Section 3.4 of the indenture).
|
A prospectus supplement may list situations for terminating a global security that would apply only to a
particular series of debt securities. When a global security terminates, the depositary, and not us or the trustee, is responsible for deciding the names of the institutions that will be the initial direct holders.
The Depository Trust Company
. Unless otherwise indicated in the prospectus supplement, The Depository Trust Company, or DTC, will
act as securities depository for the debt securities. The debt securities will be issued as fully-registered securities in the name of Cede & Co. or such other name as may be requested by an authorized representative of DTC. One
fully-registered security certificate will be issued for each debt security, each in the aggregate principal amount of such security and will be deposited with DTC.
17
Purchases of debt
securities under the DTC system must be made by or through participants (for example, your broker) who will receive credit for the securities on DTCs records. The ownership interest of each actual purchaser of each debt security will be
recorded on the records of the participant. Beneficial owners of the debt securities will not receive written confirmation from DTC of their purchase. Beneficial owners are, however, expected to receive written confirmations providing details of the
transaction, as well as periodic statements of their holdings, from the participant through which the beneficial owner entered into the transaction. Transfers of ownership interests in the debt securities are to be accomplished by entries made on
the books of participants acting on behalf of beneficial owners. Beneficial owners will not receive certificates representing their ownership interests in the debt securities except in the event that use of the book-entry system for the debt
securities is discontinued.
To facilitate subsequent transfers, all debt securities deposited by participants with DTC are
registered in the name of DTCs partnership nominee, Cede & Co., or such other name as may be requested by an authorized representative of DTC. The deposit of debt securities with DTC and their registration in the name of
Cede & Co. or such other DTC nominee do not effect any change in beneficial ownership. DTC has no knowledge of the actual beneficial owners of the debt securities; DTCs records reflect only the identity of the participants to whose
accounts the debt securities are credited, which may or may not be the beneficial owners. The participants will remain responsible for keeping account of their holdings on behalf of their customers.
Conveyance of notices and other communications by DTC to participants and by participants to beneficial owners will be governed by
arrangements among them, subject to statutory or regulatory requirements as may be in effect from time to time.
Proceeds,
distributions or other payments on the debt securities will be made to Cede & Co., or such other nominee as may be requested by an authorized representative of DTC. DTCs practice is to credit participants accounts upon
DTCs receipt of funds in accordance with their respective holdings shown on DTCs records. Payments by participants to beneficial owners will be governed by standing instructions and customary practices, as is the case with securities
held for the accounts of customers in bearer form or registered in street name, and will be the responsibility of such participant and not DTC, or Sigma-Aldrich, subject to any statutory or regulatory requirements as may be in effect
from time to time.
DTC may discontinue providing its services as depository with respect to the debt securities at any time
by giving reasonable notice to us. Under such circumstances, in the event that a successor depository is not obtained, certificates representing the debt securities are required to be printed and delivered. We may decide to discontinue use of the
system of book-entry transfers through DTC, or a successor depository. In that event, certificates representing the debt securities will be printed and delivered.
DTC is a limited-purpose trust company organized under the New York Banking Law, a banking organization within the meaning of the New York Banking Law, a member of the Federal Reserve System,
a clearing corporation within the meaning of the New York Uniform Commercial Code, and a clearing agency registered pursuant to the provisions of Section 17A of the Exchange Act. DTC holds and provides asset servicing
for over 3.5 million issues of U.S. and non-U.S. equity issues, corporate and municipal debt issues, and money market instruments (from over 100 countries) that DTCs participants deposit with DTC. DTC also facilitates the post-trade
settlement among direct participants of sales and other securities transactions in deposited securities, through electronic computerized book-entry transfers and pledges between direct participants accounts. This eliminates the need for
physical movement of securities certificates. Direct participants include both U.S. and non-U.S. securities brokers and dealers, banks, trust companies, clearing corporations, and certain other organizations. DTC is a wholly-owned subsidiary of The
Depository Trust & Clearing Corporation, or DTCC. DTCC is the holding company for DTC, National Securities Clearing Corporation and Fixed Income Clearing Corporation, all of which are registered clearing agencies. DTCC is owned by the users
of its regulated subsidiaries. Access to the DTC system is also available to others such as
18
both U.S. and non-U.S. securities brokers and dealers, banks, trust companies, and clearing corporations that clear through or maintain a custodial relationship with a direct participant, either
directly or indirectly. The DTC Rules applicable to its Participants are on file with the SEC.
The information in this
section concerning DTC and DTCs book-entry system has been obtained from sources that we believe to be reliable, but we take no responsibility for the accuracy thereof.
DESCRIPTION OF CAPITAL STOCK
General
As of the date of this prospectus, our authorized capital stock consists of 300,000,000 shares of common stock, $1.00 par value per
share. As of September 30, 2010, there were 121,298,893 shares of our common stock issued and outstanding. Our common stock currently trades on the NASDAQ Global Select Market under the symbol SIAL.
Common Stock
Holders
of our common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders and do not have cumulative voting rights. Generally, matters to be decided by the stockholders will be decided by the vote of holders
of a majority of the outstanding shares of our common stock entitled to vote on the subject matter and represented in person or by proxy at a meeting at which a quorum is present.
Holders of our common stock are entitled to receive dividends ratably, if any, as may be declared by the board of directors out of
legally available funds. Upon our liquidation, dissolution or winding-up, holders of our common stock are entitled to receive ratably its net assets available for distribution after the payment of all of our liabilities. Holders of our common stock
have no preemptive, subscription, redemption or conversion rights. The rights, preferences and privileges of holders of common stock are subject to, and may be adversely affected by, the rights of holders of shares of any series of preferred stock
that we may designate and issue at any time, including in the future.
Limitation on Liability and Indemnification Matters
Our certificate of incorporation, as amended, provides that no director shall be liable to us or our stockholders for monetary damages
for breach of fiduciary duty as a director, except for liability:
|
|
|
for any breach of the directors duty of loyalty to us or our stockholders;
|
|
|
|
for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law;
|
|
|
|
under Section 174 of the Delaware General Corporation Law (DGCL); or
|
|
|
|
for any transaction from which the director derived an improper personal benefit.
|
Our by-laws state that we shall, to the full extent permitted by the DGCL, indemnify any person who was or is a party or threatened to be
made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he is or was our director or officer or is or was serving at our request as a
director or officer of any other corporation or enterprise. The by-laws further state that we may, but shall not be required to, supplement the right of indemnification as described above by
|
|
|
the purchase of insurance on behalf of any one or more of such persons, whether or we would be obligated to indemnify such person;
|
19
|
|
|
individual or group indemnification agreements with any one or more of such persons; and
|
|
|
|
advances for related expenses of such a person.
|
We have purchased directors and officers insurance which protects each director and officer from liability for actions taken in their capacity as directors or officers. This insurance may
provide broader coverage for such individuals than may be required by the provisions of our certificate of incorporation.
Amendment of
Certificate of Incorporation and By-Laws
Under Delaware law, stockholders have the right to adopt, amend or repeal the
by-laws of a corporation. In addition, if the certificate of incorporation so provides, the by-laws may be amended by the board of directors. Our certificate of incorporation provides that our by-laws may be amended by the board of directors. Our
by-laws provide that the stockholders may amend the by-laws by an affirmative vote of the holders of not less than a two-thirds of the voting power of the shares issued and outstanding and entitled to vote at any annual or special meeting of the
stockholders at which a quorum is in attendance.
The Companys certificate of incorporation, as amended, provides that
certain provisions of the certificate of incorporation, including the provision relating to the business combinations (see Certain Anti-Takeover Effects of Provisions of the Companys Certificate of Incorporation, By-Laws and Delaware
LawLimitation on Certain Business Combinations) may only be amended with an affirmative vote of the holders of at least two-thirds of all the outstanding shares of the Company entitled to vote at a meeting of stockholders called for such
purpose.
Certain Anti-Takeover Effects of Provisions of the Companys Certificate of Incorporation, By-Laws and Delaware Law
A number of provisions in our certificate of incorporation and by-laws and Delaware law may make it more difficult to
acquire control of the Company. These provisions could deprive the stockholders of opportunities to realize a premium on the shares of common stock owned by them. In addition, these provisions may adversely affect the prevailing market price of our
common stock. These provisions are intended to:
|
|
|
enhance the likelihood of continuity and stability in the composition of the board of directors and in the policies formulated by the board of
directors;
|
|
|
|
discourage transactions which may involve an actual or threatened change in control of Sigma-Aldrich;
|
|
|
|
discourage tactics that may be used in proxy fights; and
|
|
|
|
encourage persons seeking to acquire control of Sigma-Aldrich to consult first with the board of directors to negotiate the terms of any proposed
business combination or offer.
|
These provisions include, but are not limited to, those described in the
section captioned Amendment of Certificate of Incorporation and By-Laws and the following sections:
Number
of Directors; Filling Vacancies; Removal
Our by-laws require that our board of directors consist of between three and
eleven members. Our by-laws provide that vacancies on the board of directors may be filled by a majority of the board of directors then in office, even if less than a quorum, or by the sole remaining director. A director may be removed from office
by affirmative vote of the holders of a majority of the voting power of the outstanding shares entitled to vote for the
20
election of such director, taken at a meeting of shareholders called for that purpose. Accordingly, the Board could temporarily prevent any stockholder from obtaining majority representation on
the board of directors by enlarging the board of directors and filling the new directorships with its own nominees.
Advance Notice Procedures for Stockholder Proposals and Director Nominations
Our by-laws provide that stockholders seeking to bring business before an annual meeting of stockholders, or to nominate candidates for
election as directors at an annual meeting of stockholders, must provide timely notice thereof in writing. To be timely, a stockholders notice generally must be delivered to, and received at, our principal executive offices not less than 90
nor more than 120 days prior to the first anniversary of the preceding years annual meeting of stockholders. However, if the date of the annual meeting is advanced by more than 30 days prior to or delayed by more than 60 days after the
anniversary of the preceding years annual meeting, to be timely, notice by the stockholder must be delivered not earlier than the 120th day prior to the annual meeting and not later than the close of business on the later of the 90th day prior
to such annual meeting or the tenth day following the day on which public announcement of the date of the meeting is first made. Our by-laws also specify requirements as to the form and content of a stockholders notice. Although the by-laws do
not give the Board of Directors any power to approve or disapprove stockholder nominations for the election of directors or proposals for action, they may have the effect of precluding a contest for the election of directors or the consideration of
stockholder proposals if the proper procedures are not followed, and of discouraging or deterring a third party from conducting a solicitation of proxies to elect its own slate of directors or to approve its proposal without regard to whether
consideration of such nominees or proposals might be harmful or beneficial to us and our stockholders.
Authorized but
Unissued Shares of Common Stock
The authorized but unissued shares of common stock are available for future issuance
without stockholder approval except as may be required by applicable stock exchange rules or Delaware law. These additional shares may be utilized for a variety of corporate purposes, including future public or private offerings to raise additional
capital, corporate acquisitions, and employee benefit plans and equity grants. The existence of authorized but unissued shares of common stock could render more difficult or discourage an attempt to obtain control of Sigma-Aldrich by means of a
proxy contest, tender offer, merger or otherwise. We will not solicit approval of our stockholders for issuance of common stock unless our board of directors believes that approval is advisable or is required by applicable stock exchange rules or
Delaware law.
Cumulative Voting
Our certificate of incorporation, as amended, does not authorize our stockholders to cumulate voting in the election of directors. As a result, a stockholder may not aggregate his or her votes for a
single director.
Limitation on Certain Business Combinations
Our certificate of incorporation prohibits us from approving any business combination without the affirmative vote of the holders of at
least two-thirds of all our outstanding stock entitled to vote at a meeting of stockholders called for such purpose.
The term
business combination is defined as:
|
|
|
any merger or consolidation of Sigma-Aldrich with any other corporation or the acquisition by merger or consolidation of another company by a
subsidiary of us through the issuance of a number of our shares in excess of thirty-five percent of our then outstanding shares;
|
21
|
|
|
any sale, lease exchange, transfer or other disposition (in one transaction or series of transactions) to or with any individual, corporation,
partnership or other person or entity of any of our or our subsidiaries assets (including stock of a subsidiary) that have an aggregate book value of twenty percent of our total assets as shown on our consolidated balance sheet as of the
calendar quarter immediately preceding any such transaction;
|
|
|
|
the adoption of any plan or proposal for the liquidation or dissolution of Sigma-Aldrich; or
|
|
|
|
any transaction involving us or any of our subsidiaries, including the issuance or transfer of any of our securities, any reclassification of our
securities, or a recapitalization of us or our subsidiaries, or any merger or consolidation of us with any of our subsidiaries if the transaction would have the effect, directly or indirectly, of increasing the proportionate share of the outstanding
shares of any class of our equity or convertible securities or any subsidiary which shares may be entitled to vote on the transactions set forth in the bullets above.
|
Ability to Call Special Meeting and Stockholder Action by Written Consent
Our by-laws limit the ability to call special meetings of our stockholders to the board of directors, the chairman of the board of
directors or the president of the company. Accordingly, special meetings of stockholders may not be called by stockholders. Our certificate of incorporation and by-laws provide that any action by written consent of stockholders in lieu of a meeting
must be unanimous. The provision that does not allow stockholders to call special meetings and the provision prohibiting stockholder action by written consent except when unanimous consent is obtained may delay consideration of a stockholder
proposal until the next annual meeting (unless a special meeting is called).
Delaware Anti-Takeover Law
We are subject to Section 203 of the DGCL regulating corporate takeovers. Section 203, subject to certain
exceptions, prohibits a Delaware corporation from engaging in any business combination with any interested stockholder for a period of three years following the date that such stockholder became an interested stockholder
unless:
|
|
|
prior to such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in the
stockholder becoming an interested stockholder;
|
|
|
|
upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85%
of the voting stock of the corporation outstanding at the time the transaction commenced, excluding those shares owned by persons who are directors and also officers, and employee stock plans in which employee participants do not have the right to
determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or
|
|
|
|
on or subsequent to such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of
stockholders, and not by written consent, by the affirmative vote of at least two-thirds of the outstanding voting stock that is not owned by the interested stockholder.
|
In general, Section 203 defines business combination to include mergers or consolidations between a Delaware corporation
and an interested stockholder, transactions with an interested stockholder involving the assets or stock of the corporation or its majority-owned subsidiaries and transactions which increase an interested stockholders percentage ownership of
stock. In general, Section 203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or
controlled by such entity or person.
22
DESCRIPTION OF WARRANTS
We may issue warrants to purchase debt securities, common stock or other securities described in this prospectus. We may issue warrants independently or as part of a unit with other securities. Warrants
sold with other securities as a unit may be attached to or separate from the other securities. We will issue warrants under separate warrant agreements between us and a warrant agent that we will name in the applicable prospectus supplement.
The prospectus supplement relating to any warrants we are offering will describe specific terms relating to the offering,
including a description of any other securities sold together with the warrants. These terms will include some or all of the following:
|
|
|
the title of the warrants;
|
|
|
|
the aggregate number of warrants offered;
|
|
|
|
the price or prices at which the warrants will be issued;
|
|
|
|
terms relating to the currency or currencies, in which the prices of the warrants may be payable;
|
|
|
|
the designation, number and terms of the debt securities, common stock or other securities or rights, including rights to receive payment in cash or
securities based on the value, rate or price of one or more specified commodities, currencies or indices, purchasable upon exercise of the warrants and procedures by which those numbers may be adjusted;
|
|
|
|
the exercise price of the warrants, including any provisions for changes or adjustments to the exercise price, and terms relating to the currency in
which such price is payable;
|
|
|
|
the dates or periods during which the warrants are exercisable;
|
|
|
|
the designation and terms of any securities with which the warrants are issued as a unit;
|
|
|
|
if the warrants are issued as a unit with another security, the date on or after which the warrants and the other security will be separately
transferable;
|
|
|
|
if the exercise price is not payable in U.S. dollars, terms relating to the currency in which the exercise price is denominated;
|
|
|
|
any minimum or maximum amount of warrants that may be exercised at any one time; any terms relating to the modification of the warrants;
|
|
|
|
a discussion of material federal income tax considerations, if applicable; and
|
|
|
|
any other terms of the warrants, including terms, procedures and limitations relating to the transferability, exchange, exercise or redemption of the
warrants.
|
Warrants issued for securities other than our debt securities or common stock will not be
exercisable until at least one year from the date of sale of the warrant.
The applicable prospectus supplement will describe
the specific terms of any warrant units.
The descriptions of the warrant agreements in this prospectus and in any prospectus
supplement are summaries of the material provisions of the applicable agreements. These descriptions do not restate those
23
agreements in their entirety and do not contain all of the information that you may find useful. We urge you to read the applicable agreements because they, and not the summaries, define many of
your rights as holders of the warrants or any warrant units. For more information, please review the form of the relevant agreements, which will be filed with the SEC promptly after the offering of warrants or warrant units and will be available as
described under the heading Where You Can Find More Information.
DESCRIPTION OF
PURCHASE CONTRACTS
We may issue purchase contracts obligating holders to purchase from us, and us to sell to the holders,
a number or amount of debt securities, shares of our common stock or warrants at a future date or dates. The price per equity security and the number of securities may be fixed at the time the purchase contracts are issued or may be determined by
reference to a specific formula stated in the purchase contracts. The purchase contracts may require us to make periodic payments to the holders of the purchase contracts. The payments may be unsecured or prefunded on some basis to be specified in
the applicable prospectus supplement.
The prospectus supplement relating to any purchase contracts we are offering will
describe the material terms of the purchase contracts and any applicable pledge or depository arrangements, including one or more of the following:
|
|
|
the stated amount a holder will be obligated to pay in order to purchase our debt securities, common stock or warrants or the formula to determine such
amount;
|
|
|
|
the settlement date or dates on which the holder will be obligated to purchase the securities. The prospectus supplement will specify whether certain
events may cause the settlement date to occur on an earlier date and the terms on which an early settlement would occur;
|
|
|
|
the events, if any, that will cause our obligations and the obligations of the holder under the purchase contract to terminate;
|
|
|
|
the settlement rate, which is a number that, when multiplied by the stated amount of a purchase contract, determines the number of securities that we
will be obligated to sell and a holder will be obligated to purchase under that purchase contract upon payment of the stated amount of a purchase contract. The settlement rate may be determined by the application of a formula specified in the
prospectus supplement. If a formula is specified, it may be based on the market price of such securities over a specified period or it may be based on some other reference statistic. Purchase contracts may include anti-dilution provisions to adjust
the number of securities to be delivered upon the occurrence of specified events;
|
|
|
|
whether the purchase contracts will be issued separately or as part of units consisting of a purchase contract and an underlying security with an
aggregate principal amount equal to the stated amount. Any underlying securities will be pledged by the holder to secure its obligations under a purchase contract. Underlying securities may be our debt securities, common stock, warrants or debt
obligations or government securities;
|
|
|
|
the terms of any pledge arrangement relating to any underlying securities; or
|
|
|
|
the amount of the contract fee, if any, that may be payable by us to the holder or by the holder to us, the date or dates on which the contract fee
will be payable and the extent to which we or the holder, as applicable, may defer payment of the contract fee on those payment dates. The contract fee may be calculated as a percentage of the stated amount of the purchase contract or otherwise.
|
The descriptions of the purchase contracts and any applicable underlying security or pledge or depository
arrangements in this prospectus and in any prospectus supplement are summaries of the material provisions of
24
the applicable agreements. These descriptions do not restate those agreements in their entirety and may not contain all the information that you may find useful. We urge you to read the
applicable agreements because they, and not the summaries, define many of your rights as holders of the purchase contracts. For more information, please review the form of the relevant agreements, which will be filed with the SEC promptly after the
offering of purchase contracts or purchase contract units and will be available as described under the heading Where You Can Find More Information.
DESCRIPTION OF UNITS
As specified in the
applicable prospectus supplement, we may issue units comprised of one or more of the other securities described in this prospectus in any combination. Each unit may also include debt obligations of third parties, such as U.S. Treasury securities.
Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The prospectus supplement will
describe:
|
|
|
the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances the securities
comprising the units may be held or transferred separately;
|
|
|
|
a description of the terms of any unit agreement governing the units;
|
|
|
|
a description of the provisions for the payment, settlement, transfer or exchange of the units;
|
|
|
|
a discussion of material federal income tax considerations, if applicable; and
|
|
|
|
whether the units will be issued in fully registered or global form.
|
The descriptions of the units and any applicable underlying security or pledge or depository arrangements in this prospectus and in any
prospectus supplement are summaries of the material provisions of the applicable agreements. These descriptions do not restate those agreements in their entirety and may not contain all the information that you may find useful. We urge you to read
the applicable agreements because they, and not the summaries, define many of your rights as holders of the units. For more information, please review the form of the relevant agreements, which will be filed with the SEC promptly after the offering
of units and will be available as described under the heading Where You Can Find More Information.
PLAN OF DISTRIBUTION
We or any selling security holder may sell any of the securities being offered by this
prospectus in any one or more of the following ways from time to time:
|
|
|
through agents or dealers;
|
|
|
|
to or through underwriters;
|
|
|
|
directly by us or by any selling security holder to purchasers; or
|
|
|
|
through a combination of any of these methods.
|
We will describe the details of any such offering and the plan of distribution for any securities offering by us or any selling security holder in a prospectus supplement.
25
LEGAL MATTERS
Unless otherwise indicated in the applicable prospectus supplement, Bryan Cave LLP, St. Louis, Missouri, will issue an opinion about the validity of the securities.
EXPERTS
The consolidated financial statements of Sigma-Aldrich Corporation as of December 31, 2009 and 2008, and for each of the years in the three-year period ended December 31, 2009, and managements
assessment of the effectiveness of internal control over financial reporting as of December 31, 2009 have been incorporated herein and in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting
firm, incorporated herein and in the registration statement, and upon the authority of said firm as experts in auditing and accounting. The report of KPMG LLP refers to the companys adoption of an interpretation of Statement of Financial
Accounting Standards No. 109 (ASC 740) effective January 1, 2007.
26
$300,000,000
3.375% Senior Notes due 2020
Sigma-Aldrich Corporation
PROSPECTUS SUPPLEMENT
October 25, 2010
Joint
Book-Running Managers
BofA Merrill Lynch
J.P. Morgan
(MM) (NASDAQ:SIAL)
Historical Stock Chart
From May 2024 to Jun 2024
(MM) (NASDAQ:SIAL)
Historical Stock Chart
From Jun 2023 to Jun 2024